UCSF Helen Diller Family Comprehensive Cancer Center
Protocol Search Results
926 protocols in [Age Group: A]

[ Print this page ]

Protocol No.Title
001-15A Multicenter, Prospective, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study of BB3 to Reduce the Severity of Delayed Graft Function in Recipients of a Deceased Donor Kidney
02049307Losartan to reduce Inflammation and Fibrosis Endpoints in HIV Trial
05161131-I-Metaiodobenzylguanidine (131-I-MIBG) Therapy for Refractory Neuroblastoma: A Best Available Therapy/Compassionate Use Protocol
05982APEXZZ Detection and Characterization of Circulating Cells in Cancer Patients (Stage IV Micromets)
08754APEXZZ Functional MR Imaging of the Breast
097517I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2)
09994131I-Metaiodobenzylguanidine(131I-MIBG) Therapy for Patients with Malignant Pheochromocytoma & Related Tumors
10-00104Immunogenetic Studies in Multiple Sclerosis
10-00207Discovery of Gene Mutations and Polymorphisms that Contribute to the Risk of Cardiovascular and Metabolic Disease and Macular Degeneration.
10-00234Establishment of Neurodegenerative Disease Patient Induced Pluripotent Stem (iPS) Cell Lines
10-00265In Vitro Analysis of Human Leukocyte Immune Responses.
10-00350 Maternal-fetal immune responses in preterm labor and congenital anomalies
10-00353Mediators of Atherosclerosis in South Asians Living in America
10-00359Predictors of Outcome After Subarachnoid Hemorrhage
10-00361An Observational Study of the Natural History of Outcomes in Hemophilics Undergoing Major Orthopedic Surgery
10-00515Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC), part of the Childhood Liver Disease Research and Education Network (ChiLDREN)
10-00610Clinical and neurocognitive assessment in adolescents and young adults at risk for serious psychiatric disorders
10-00727Cerebrospinal Fluid Analysis of HIV-1 Viral Burden in HIV-1 Infected Subjects: Response to Antiretroviral Therapy
10-00824Neural synchrony in mental illness
10-00889Genes-Environment, Admixture and Latino Asthmatics (GALA II) Study
10-01241Genetics of Familial Cholestasis
10-01329Mechanisms of Exacerbation of Asthma
10-01337Genetic Epidemiology of Ovarian Aging
10-01355Clinical and Molecular Investigation of Primary Immunodeficiencies
10-01494Network neuroimaging and quantitative neuropathology in neurodegenerative disease
10-01501EVALUATION OF VASCULAR PATHOLOGY USING 4D FLOW MRI IMAGING
10-01592Interstitial Lung Disease Database
10-01592-APEXInterstitial Lung Disease Database
10-01784A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
10-02012Predictors of Outcome in Patients with Strokes and Brain Injury - a Multicenter Arteriovenous Malformation Research Study (MARS)
10-02190Alopecia Areata Registry and Immunogenetic Mechanism
10-02323Effector function of NKT cells in Sarcoidosis
10-02389Banking of Cerebrospinal Fluid and/or Peripheral Blood from patients with Multiple Sclerosis, Neuromyelitis optica and other neurological diseases or from healthy subjects.
10-02467Genetics of Tissue-specific Autoimmunity
10-02515Evolution and Progression of Myelin Injury and Cognitive Manifestations in Fabry Disease
10-02534Randomized Trial of Rosuvastatin for Acutely Injured Lungs from Sepsis SAILS: Statins for Acutely Injured Lungs from Sepsis
10-02701Acute Lung Injury in Critically Ill Patients
10-02710Postoperative cognitive function in elderly surgical patients
10-02830Genetic Risk Factors for Inflammatory Skin Disease
10-02877Study of African Americans, Asthma, Genes, and Environments (SAGE)
10-02888iPS Cells for Studying Neurodegenerative Disease
10-04016Cognitive and Behavorial Control in Frontotemporal Dementia
10-04135Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus (TrialNet Protocol TN-07)
10-04170Induced Pluripotent Stem Cells for Cardiovascular Research
10-04522"Preventing Inter-Generational Transmission of Stress Vulnerability and Obesity in at-risk Populations"
10-04600INFLUENZA VIRUS INFECTIONS IN TRANSPLANT RECIPIENTS: A MULTICENTER REGISTRY
10-04615The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease (Blood Draw and Dietary Questionnaire)
10-04912Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B
10-04950Prospective, Multi-center Adult Spinal Deformity Outcomes Database Registry
10-05034PEDIATRIC MULTIPLE SCLEROSIS COHORT
10-05039 Environmental and genetic risk factors for pediatric multiple sclerosis"
1002703The Infant Development and Environment Study
10082An Expanded Access Study of the Feasibility of Using the CliniMACS® Device for CD34+ Cell Selection and T Cell Depletion for Graft-versus-Host Disease Prophylaxis in Alternative Donor Stem Cell Transplant Recipients
11-05319MRI CHARACTERIZATION OF INFLAMMATORY CELLS IN PATIENTS WITH VASCULAR MALFORMATIONS OF THE BRAIN
11-05353Smart Diaphragm: A pilot study of a novel device to reduce the incidence of preterm birth and improve pregnancy outcomes
11-05363Phase 1 Study of Interactions between Oral Naltrexone and Bupropion and Intravenous Methamphetamine in Methamphetamine Experienced Volunteers
11-05707Blood draw from healthy volunteers and patients on hem dialysis to study the effects of serum from patients with Chronic Kidney Disease on Hepatic transporters in cell cultures.
11-05719Molecular Genetic Analysis of Patients with Multiple Congenital Anomaly Syndromes
11-06034A Randomized, Placebo-Controlled, Multi-Site Phase 2 Study Evaluating the Safety and Efficacy of Preemptive Treatment with CMX001 for the Prevention of Adenovirus Disease Following Hematopoietic Stem Cell Transplantation (The ADV HALT Trial).
11-06163Risk Factors for Infant Overweight in a Latino Cohort
11-06179Passive Smoke and Outcomes in Congestive Heart Failure
11-06356Platelet-Oriented Inhibition in New TIA and minor ischemic stroke (POINT)
11-06454Comprehensive Brain Imaging In Genetically Defined Autism Patients
11-06476An Assessment of P-15 Bone Putty in Anterior Cervical Fusion with Instrumentation
11-06556Natural History of and Genetic Modifiers in Spinocerebellar Ataxias
11-07311COVERED CHEATHAM PLATINUM STENT FOR PREVENTION OR TREATMENT OF AORTIC WALL INJURY ASSOCIATED WITH AORTIC COARCTATION (COAST II)
11-07551Impact of HIV on Gut Mucosal Immunity
11-07994BeNEG-DO: A Study of Clinical Outcomes, Immunologic Correlates and Genetic Predictors After Treatment Withdrawal in Early-Antigen Negative (HBeAg ) Chronic Hepatitis B Virus (HBV) Infection
11-08297Sleep disruption and postoperative delirium
11-08325Cornea Preservation Time Study (CPTS): Effect of Corneal Preservation Time on Long-Term Graft Success
112516A Multicenter Phase I Dose-Finding and Preliminary Efficacy Study of the Histone Deacetylase Inhibitor Romidepsin (Istodax®) in Combination with Doxorubicin HCl Liposomal (or Doxil®) for the Treatment of Adults with Relapsed or Refractory T-cell Lymphomas
1199-247A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nintedanib over 52 weeks in patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
11996A Phase 1b/ll Study of Eribulin in Combination with Cyclophosphamide in Patients with Solid Tumor Malignancies
12-08593Analysis of the Blood and Urine in Kidney Transplant Recipients
12-08773Postoperative sleep and cognition in Obstructive Sleep Apnea patients
12-09465Transforming Research and Clinical Knowledge in Traumatic Brain Injury U01
12-09480Long Term Investigative Follow-Up In TrialNet (LIFT) (Protocol TN-16)
12-09598Combination Therapy of Peginterferon Alfa-2a and Tenofovir versus Tenofovir Monotherapy in HBeAg-positive and HBeAg-negative Chronic Hepatitis B
12-09605Emotion and Social Behavior in Age-Related Disorders
12-09824UCSF HIV Over 60 Cohort Study
12-10269PET Characterization of Inflammation in Patients with Vascular Malformations of the Brain
12-10330CTLA-4 Ig (Abatacept) FOR PREVENTION OF ABNORMAL GLUCOSE TOLERANCE AND DIABETES IN RELATIVES AT-RISK FOR TYPE 1 DIABETES MELLITUS (TrialNet Protocol TN-18)
12-10504The Effect of Soluble Urokinase Plasminogen Activation Receptor (suPAR) and Blocking Agents on Podocyte Activation in Normal Kidneys
120817Phase II Study of Everolimus for Recurrent or Progressive Low-Grade Gliomas in Children
120819Safety, Phase 0, and Pilot Efficacy Study of Vemurafenib, an Oral Inhibitor of BRAFV600E, in Children and Young Adults with Recurrent/Refractory BRAFV600E- or BRAF Ins T-mutant Brain Tumors
12084Pediatric Myelodysplastic Syndrome and Bone Marrow Failure Disorder Registry and Tissue Repository
12088124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients with Neuroblastoma: A Pilot Study
122011A Phase II Study of Radiation Therapy and Vismodegib, for the Treatment of Locally Advanced Basal Cell Carcinoma of the Head and Neck
12557A Randomized Phase 2 Trial of Immediate versus Delayed Anti-CTLA4 Blockade Following Sipuleucel-T Treatment for Prostate Cancer Immunotherapy
127522Translating Cancer Genetics for the Safety Net Setting
127536Evaluation of Intra-Operative Ultrasound Guided Excision using the Hydromark Clip as an Alternative to Needle Localization for Non-Palpable Breast Lesions
12985The Effect of Tyrosine Kinase Inhibitors on Male Reproductive Health and Spermatozoa Function: A Prospective Observational Study of Men Receiving TKI for Treatment of Malignant Tumors
13-10596A Phase 1, Open-labeled, Dose Escalation, Multi-center Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome
13-10738Lung Transplantation: Improving outcomes through the development of a clinical database and biorepository
13-11224Multimodal Imaging of Language in the Evaluation of Epilepsy
13-11418Recruitment and screening registry at UCSF
13-11712Effect of genetic variation of transporters and genes associated with metformin on metformin levels and adverse effects associated with metformin
13-11778The Effects of Omega-3 Fatty Acids on Peripheral Artery Disease II (Omega-PAD II)
13-11849Immune modulation by Tecfidera in multiple sclerosis
13-11929Multicenter Phenotypic and Genetic Analysis of Vascular Overgrowth Syndromes
13-11974CDC Public Health Surveillance for Bleeding Disorders Registry for Bleeding Disorders Surveillance
13-12160Effects of EDCs and Chronic Psychosocial Stress on Fetal Growth
13-12236Pathogen and Autoantibody Discovery in Unexplained Diseases of the Nervous System
13-12346Effects of Sensorimotor Therapies on Hand Rehabilitation in Chronic Acquired Brain Injury Pilot Study
13-12489Is Discogenic Low Back Pain a Subclinical Disc Infection? The BackBug Study
13-12666Observational Study of Hepatitis B virus (HBV) in patients Coinfected with Human Immunodeficiency Virus (HIV)
13-12765Online Neuropsychological Test Validation Project with Imaging Pilot
131012PI3K/mTOR Pathway Activation-Stratified Phase II Study of RAD001 (Everolimus) with and without Temozolomide in the Treatment of Adult Patients with Supratentorial Low-Grade Glioma
13553Prostate Cancer Decision Making for Low-Income African American Men
138510Tissue Bank of Human Biospecimens for Molecular Studies of Mechanisms of Resistance or Response to Therapy in Melanoma and Other Solid Tumors: UCSF Melanoma Tissue Bank (MTB)
13852Melanoma Biomarkers in Blood
139510Phase Ib Study of Ficlatuzumab with High Dose Cytarabine in Relapsed and Refractory AML
139511A Phase Ib Study of SAR650984 (Anti-CD38 mAb) in Combination with Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma
14-12976Housing as a Structural Intervention for Substance Use & HIV in Unstably Housed Youth
14-13003Multimodality Imaging in Knee Osteoarthritis
14-13071Effects of Ultrasound-guided Adductor Canal Block Versus Femoral Nerve Block on Pain and Quadriceps Strength After Ambulatory Knee Arthroscopic Surgery
14-13100Filipinos Fit and Trim Weight Loss for Diabetes Prevention Program
14-13118Effects of IUDs and levonorgestrel on the mucosal immune environment in the female reproductive tract
14-13123The Use of Fish oil to Reduce Inflammation Caused By a Peripheral VascularIntervention (OMEGA-PVI)
14-13146Randomized control trial of nitroglycerin during cesarean delivery in the second stage of labor
14-13172Multiple Patient Program for Lamprene® (clofazimine) for the treatment of Non-Tuberculous Mycobacterial (NTM) Infections
14-13337Evaluation of cardiac sarcoid with Gallium-68 HA-DOTA-TATE
14-13472Intra-anal Imiquimod 2.5% vs. Topical 5-fluorouracil 5% vs. Observation for the Treatment of High-grade Anal Squamous Intraepithelial Lesions in HIV-positive Men and Women
14-13597The Impact of Type 1 Diabetes Mellitus on Bone Microarchitecture
14-13676Nonalcoholic Fatty Liver Disease (NAFLD) FibroScan® Protocol
14-13889The effects of perspective-taking on affect contagion within dyadic social interactions
14-13899Concomitant Administration of FSH With A Low Dose Of hCG (1500 IU) Has Equivalent Oocyte Developmental Competence While Decreasing The Exposure To hCG In In Vitro Fertilization Cycles: A Double Blind Randomized Control Trial
14-14062Follow-Up of Persons with Neurological Diseases in Parkinson's Progression Markers Initiative
14-14139Defining a Comprehensive Reference Profile of Circulating Human Extracellular RNA
14-14248Development of a Multi-Ethnic, Multimodal Obesity Cohort
14-14273The Effect of Anesthetic Depth on Postoperative Cognitive Outcomes, II
14-14352TREATMENT OF TYPE 1 DIABETES BY ISLET TRANSPLANTATION INTO THE GASTROINTESTINAL SUBMUCOSA
14-14355Bevacizumab Therapy for Unruptured Brain Arteriovenous Malformations
14-14409The Use of Pocket-sized Handheld Ultrasound to assess Distal Radius Fracture Deformity and Quality of Reduction
14-14484STAR (Service, Training, Advocacy & Research) Center for ASD and NDDs
14-14513Changes in jejunal enterocyte, villus/crypt morphology and expression of brush border enzymes following Laparoscopic Roux-en-Y Gastric Bypass Surgery.
14-14533To establish a registry to obtain patient clinical data, biopsy material and stone material.
14-14537Care Ecosystem: Navigating Patients and Families through Stages of Care
14-14585Predictors and Mechanisms of Serious Mental Illness: The North American Prodrome Longitudinal Study
14-14589Biomarkers in Ocular Sarcoidosis Study
14-14790Longitudinal evaluation of HIV-associated lung disease phenotypes
14-14857-APEXA Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiac Surgery with Cardiopulmonary Bypass
14-14873Matrix Stiffness in Normal and Diseased Human Livers
14-15191A Randomized Trial to Evaluate an Electronic CKD Clinical Decision Support System (CDSS) in Clinical Care
14-15201Excimer Laser Phototherapy Outcomes in the Treatment Of Psoriasis: A randomized clinical trial to determine whether a novel plaque-based dosimetry strategy can improve the speed of response to treatment in patients with plaque psoriasis
14-15334Comparing Options for Management: Patient-centered Results for Uterine Fibroids
14-15367Methodological Studies of MRI of the Human Brain
14-15411Brain Vascular Malformation Consortium: Predictors of clinical course. Project 1: Modifiers of Disease Severity and Progression in Cerebral Cavernous Malformation (CCM)
14-15466Esophageal Manometry During Recovery from Anesthesia: Pilot Study
14-15555CFCARIESFissure Caries Inhibition Study with Solea CO2-9.3 μm short-pulsed laser - A randomized, single blind, prospective, split mouth controlled, clinical trial.
14-15601Polycystic Kidney Disease study
14-15627Response to biologic therapy is predicted by changes to microbiota
14082A Pilot Trial Testing the Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan in Children and Young Adults with Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)
14083An Open-Label, Dose-Escalation, Phase I/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor Trametinib in Children and Adolescent Subjects with Cancer or Plexiform Neurofibromas and Trametinib in Combination with Dabrafenib in Children and Adolescents with Cancers Harboring V600 Mutations
144526A Pilot Study of PET/MRI Localization of Yitrrium-90 Microspheres Following Hepatic Radioembolization in Patients with Liver Malignancies
14524A Phase II Study of the Anti-PD-L1 Antibody MPDL3280A in Subjects with Non-Metastatic Transitional Cell Carcinoma of the Bladder
14559An Open Label, Randomized Phase 2 Trial of Prostvac and Ipilimumab as Monotherapy or in Combination for Men with Localized Prostate Cancer Undergoing Radical Prostatectomy
14636Does Real World Exposure to FDA Graphic Warnings Affect Tobacco Use Behavior?
147522Palbociclib in Combination with Fulvestrant or Tamoxifen as Treatment for Hormone Receptor Positive Metastatic Breast Cancer with Prior Chemotherapy for Advanced Disease: A Phase II study with Pharmacodynamics Markers (TBCRC035)
147523Reversing Therapy Resistance with Epigenetic-Immune Modification (Pembrolizumab, Vorinostat, Tamoxifen)
147531Biomarker and Phenotypic Risk Factors for Breast Cancer Lymphedema
148511Determine the Prevalence of Kinase Fusions in Patients with Metastatic Melanoma in Need of Treatment
14859Phase II Trial of Targeted Kinase Fusion Inhibition in Unresectable Stage III/IV BRAF/NRAS Wild-Type Melanoma
149510A Phase 1 Study of ES414 in Patients with Metastatic Castration-Resistant Prostate Cancer
15-15676Effects of Tolcapone on Decision Making and Alcohol Intake Using a Laboratory Bar in Moderate to Heavy Social Drinkers
15-15795Women s Adherence and Visit Engagement Study
15-15878Assessment of uterine pH at time of implantation
15-15927METABOLIC AND STRUCTURAL ASSESSMENT IN EPILEPSY USING 7 TESLA MRI
15-15987Infections and other complications of cirrhosis: A prospective multi-center study
15-16019Periocular and Intravitreal Corticosteroids for Uveitic Macular Edema (POINT) Trial
15-16045 tAilored dRug Titration through artificial intElligence: an inteRventional studY (ARTERY)
15-16187Vascular effects of Infection in Pediatric Stroke (VIPS II) Study
15-16212Urinary HER2 as a biomarker for lupus nephritis
15-16368Multi-center Randomized Controlled Trial of Refeeding in Anorexia Nervosa.
15-16443Cervical Spondylotic Myelopathy Surgical Trial (CSM-S)
15-16461The influence of HIV infection on the natural history of nonalcoholic fatty liver disease
15-16463 UCSF Scleroderma Center Cohort
15-16536Circulating Biomarkers in Parkinson's Disease
15-16764Osseointegrated Percutaneous Prosthetic System For Transfemoral Amputees; a Prospective Cohort Study
15-16824Neural Correlates of Discrimination and Generalization in Recognition Memory
15-16839Efficacy, safety, and pharmacokinetics of sulphadoxine-pyrimethamine-amodiaquine (SP-AQ), SP-AQ plus primaquine, dihydroartemisin-piperaquine (DP), DP plus methylene blue for preventing transmission of P. falciparum gametocytes in Mali
15-17005Postoperative management of groin flaps for vascular coverage - analyzing the impact of bedrest on outcomes
15-17226Assessment of 2012 Bio-equivalence Standards for Narrow Therapeutic Index Drugs: A Study with Warfarin
15-17230Clinicopathological Validation of the Tau PET Tracer [18F] AV1451 in Frontotemporal Dementia: A Multi-Center Pilot Study
15-17264Antral length and GERD following sleeve gastrectomy for morbid obesity
15-1733518FGE-180 PET-MRI after Traumatic Brain Injury
15-17400A study of Clinical Outcomes in Patients with Newly Diagnosed Sarcoidosis
15-17407Development Of 18F-GE-180 PET/MR as a Biomarker for Image Guided Treatment of Low Back Pain.
15-17428A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Clemastine Fumarate as a Remyelinating Agent in Acute Demyelinating Optic Neuritis
15-17440Analytic Treatment Interruption to Study Viral Reservoirs and as a Test for Cure in HIV-infected Adults on Long-term Suppressive Antiretroviral Therapy
15-17478Can contrast-enhanced ultrasound replace fluoroscopic nephrostogram?
15-17491Lung Function In Latinos With Cystic Fibrosis
15-17503Treating frailty in lung transplant candidates
15-17547Establishing new benchmarks for measuring progression of macular degeneration
15-17569Doxycycline: A Novel Treatment for Cardiorenal Syndrome
15-17575Flat Panel Computed Tomography Imaging Post-Operative Assessment of Music Perception in Cochlear Implants Users
15-17576A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
15-17586Pharmacokinetics Distribution of Raltegravir using Radiolabeling with F-18 in HIV-infected Patients by PET/MR: a Pilot Study.
15-17591Acute to Recovery Care for Hospitalized Elders Study (ARCHES)
15-17595Randomized controlled trial comparing ureteroscopic to percutaneous removal of the 1-2 cm calculus measuring quality of life as the primary outcome.
15-17639Measuring fluctuations of pain states in chronic neuropathic pain patients
15-17757Pilot study on the role of A20 in the etiology and pathogenesis of inflammatory bowel disease
15-17761Ocular Hypertension Treatment Study: 20 year follow up
15-17794Conditioned LEArning of pain Relief (CLEAR) Study: Testing analgesic efficacy of sensory conditioning cues in human experimental pain.
15-17825PSILOCYBIN-ASSISTED GROUP THERAPY FOR DEMORALIZATION IN LONG-TERM AIDS SURVIVORS
15-17966BNP: A POTENTIAL BIOMARKER TO PREDICT THE RESPONSE TO INHALED NITRIC OXIDE (NO) THERAPY IN NEONATES, INFANTS, AND CHILDREN
15-18004A placebo-controlled pilot trial evaluating the effect of a tissue selective estrogen complex on menopausal symptoms in women with multiple sclerosis
15-18039The utility of maternal hyperoxia in predicting fetal pulmonary vasculature reactivity in fetuses at risk for pulmonary hypertension
15-18066Optical Body Composition and Health Assessment Study
15-18130Effects of Sleeve Gastrectomy on Calcium Metabolism and the Skeleton
15-18138CONGENITAL HEART DISEASE GENETIC NETWORK STUDY (CHD GENES)
15-18143Phase II-b Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus crispatus CTV-05 (LACTIN-V) to Prevent the Recurrence of Bacterial Vaginosis
15-18171Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis
15-18189A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis
15-18202Cryoanalgesia vs. Thoracic Epidural for Post-operative Pain Control following the Nuss Procedure
15-18208A pilot study of imaging CNS inflammation in HIV infection using a novel PET Tracer, GE180
15-18222Derivation and propagation of clinical-grade human embryonic stem cell lines
15-18223Innate Immunity in Ozone-induced Airway Inflammation in COPD
15-18262Parkinson's Disease MRI Biomarkers
15-18284Ultrasound characteristics of peripheral nerves in anti-myelin associated glycoprotein neuropathy.
15-18343MicroVention Low-profile Visualized Intraluminal Support Device
15-18362Validation of Tele-EDSS for use in remote multiple sclerosis monitoring
15-18415A Phase 1 study to evaluate the safety and tolerability of tandemly-purified allogeneic CD34+CD90+ HSC administered following conditioning with AMG 191 to achieve engraftment and immune reconstitution in patients with SCID
15-18419A double blind, randomised, placebo-controlled trial evaluating efficacy and safety of oral nintedanib treatment for at least 52 weeks in patients with Systemic Sclerosis associated Interstitial Lung Disease (SSc-ILD).
15-18425Precision Diagnosis of Acute Infectious Diseases
15-18466Evaluation of systemic emboli following PAVM embolization using intra-procedural transcranial Doppler, comparing the MVP versus AVP embolization
15-18472Transdermal Nitroglycerin Therapy for Menopausal Hot Flashes
15-18478AN OPEN-LABEL, MULTICENTER, BIOMARKER STUDY TO EXPLORE THE MECHANISM OF ACTION OF OCRELIZUMAB AND B-CELL BIOLOGY IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
15-18491Surgical Repair of Proximal Hamstring Avulsion Injuries: Functional Outcomes and Ultrasound Confirmation of Healing
15-18506Epigenetic Regulation of Wilson Disease
150812PNOC 005: A Phase 1 Study of Modified Measles Virus (MV-NIS) for the Treatment of Children and Young Adults with Recurrent Medulloblastoma or Recurrent Atypical Teratoid Rhabdoid Tumors (ATRT)
150814Multicenter Cohort Study To Evaluate Outcomes after Receipt of Targeted Therapy Matched to an Individualized Cancer Therapy (iCat) Recommendations in Children and Young Adults with Recurrent, Refractory, or High Risk Solid Tumors: The iCat2, GAIN Consortium Study
150818Phase II Study of Clofarabine in Patients with Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders
15084Discovering Therapeutic Targets Using Circulating Tumor DNA in Pediatric Patients with Solid and CNS Malignancies: A Pilot Study
151011A Phase 1, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-881 in Patients with Advanced Solid Tumors, Including Gliomas, with an IDH1 and/or IDH2 Mutation
151013A Feasibility Study of Gallium-68 Citrate PET to Detect Hyperactive mTOR Activity in Glioma
15103Pilot Randomized Neo-adjuvant Evaluation of Poly-ICLC-Assisted Tumor Lysate Vaccines in Adult Patients with WHO Grade II Glioma
15105Brain Tumor Funders’ Collaborative: Molecular Genetic, Host-Derived and Clinical Determinants of Long-Term Survival in Glioblastoma
15108Pilot Randomized Neo-Adjuvant Evaluation of Agonist Anti-CD27 Monoclonal Antibody Varlilumab on Immunologic Activities of IMA950 Vaccine plus Poly-ICLC in Patients with WHO Grade II Low-Grade Glioma (LGG)
15109A Phase 1a/1b Study of FPA008 in Combination with Nivolumab in Patients with Selected Advanced Cancers
1517550Trial of FG-3019, a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects with Duchenne Muscular Dystrophy
152010A Multicenter, Randomized, Open-label, Phase III Clinical Trial of Gemcitabine and Carboplatin followed by Epstein-Barr Virus-specific Autologous Cytotoxic T-Lymphocytes versus Gemcitabine and Carboplatin as First Line Treatment for Advanced Nasopharyngeal Carcinoma Patients
15205SPORE (Specialized Program of Research Excellence) in Head and Neck Cancer
152514A Phase II Study of IRD (Ixazomib, Lenalidomide, and Dexamethasone) for Consolidation Therapy Post Autologous Stem Cell Transplantation followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
152516A PHASE 1/2, OPEN-LABEL, UNCONTROLLED, MULTIPLE-DOSE ESCALATION, COHORT EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PRELIMINARY EFFICACY OF ASN002 IN RELAPSED/REFRACTORY LYMPHOMA, MYELOFIBROSIS, CHRONIC LYMPHOCYTIC LEUKEMIA AND ADVANCED SOLID TUMORS
152519Clinical-Grade Molecular Profiling of Patients with Multiple Myeloma and Related Plasma Cell Malignancies (MMRF-002)
154520Lifestyle and Patient Outcomes after Gastrointestinal Cancer: A Prospective Cohort Study (LACE)
154521Gallium-68 Citrate PET to Detect MYC Amplification and Transferring Receptor Expression in Hepatocellular Carcinoma (HCC)
154526Identification of Molecular Determinants of Esophageal Cancer in Tanzania (MDEC-TZ)
155510A Clinical Trial of High-Intensity Aerobic and Resistance Exercise for Metastatic Prostate Cancer
155513A Randomized Controlled Clinical Trial of a Smartphone-Based App to Improve Urinary and Sexual Function Outcomes after Robot-Assisted Laparoscopic Radical Prostatectomy Surgery
155518Precision Oncology and Molecular Targeting in Advanced Prostate Cancer: Identifying Predictive Markers of Response (The "PROMOTE" Study)
15632Mobile Technology to Improve Treatment Engagement and Outcomes in Smokers with Post-Traumatic Stress Disorder:Pilot
15635Clinical Pharmacology of Electronic Cigarettes
15636Teen Exposure to Active and Secondhand Tobacco Smoke
156512A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel with or without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma
15657A Phase 1/1b Study of MGCD516 in Patients with Advanced Solid Tumor Malignancies
15658An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
157515A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Patients with HER2+ Metastatic Breast Cancer Who Have Received Two Prior Anti-HER2 Therapies and Require Systemic Treatment
157521A Randomized Phase II Study of Pembrolizumab, an anti-PD(programmed cell death)-1 Antibody, in Combination with Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients with Chest Wall Disease
15753An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Intensive Loperamide Prophylaxis
15754Breast Capsular Contracture following Post-Mastectomy Reconstruction in Women Treated with the Leukotriene Inhibitor Zafirlukast: A Phase II Trial
159516A Phase Ib, Open-Label Study of Alpelisib (BYL719) in Combination with Cisplatin in Patients with HPV+ Solid Tumor Malignancies
159518A Phase I, First-Time-in-Human Study of MEDI9197, a TLR 7/8 Agonist, Administered Intratumorally as a Single Agent in Subjects with Solid Tumors or CTCL and in Combination with Durvalumab and Palliative Radiation in Subjects with Solid Tumors
159520A Platform Study Exploring the Safety, Tolerability, Effects on the Tumor Microenvironment, and Efficacy of Pembrolizumab (MK-3475) + INCB Combinations in Advanced Solid Tumors
15956A Phase 1, Open-Label, Dose Finding Study of CC-90002, a Monoclonal Antibody Directed against CD47, in Subjects with Advanced Solid and Hematologic Cancers
15981Molecular Profiling in Bone and Soft Tissue Malignancies
15989Preoperative Guided Imagery in Patients Undergoing Urology Surgery
15991Developing a Yoga Intervention During Cancer Chemotherapy
16-18534Development of Patient-Specific Retinal Cells from Induced Pluripotent Stem Cell for Generating Human Retinal Models of Eye Diseases
16-18550SORTING AND EXPRESSION PROFILING OF AIRWAY CELLS FROM HUMANS (THE SEARCH STUDY)
16-18557Early detection of diabetic nephropathy
16-18617Deep brain stimulation (DBS) in patients with refractory chronic neuropathic pain
16-18635Countering the Gastric pH Effect of a Standardized Meal in Healthy Volunteers Using Clinical Doses of Betaine Hydrochloride
16-18649Human Communication Network Plasticity
16-18658Retinal eye-tracking to screen and track neurodegenerative disease
16-18705Metagenomic Contributions to Type 2 Diabetes Among Filipino Populations
16-18725Type 2 Diabetes Mellitus and Knee Cartilage Composition Baseline Association and Longitudinal Changes Related to Metabolic Syndrome and Life Style Factors
16-18756IDAPT A Randomized Controlled Trial of Combination Isosorbide Dinitrate and Aldactazide (Spironolactone-Hydrochlorothiazide) Preload-Reducing Therapy in Patients with Arrhythmogenic Right Ventricula
16-18776Improving Frontal Emotion Regulation by Targeting Sleep
16-18896Investigating the effects of responsive neurostimulation on sleep in patients with epilepsy
16-19022A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal CD4+CD25+CD127lo/- FOXP3+ Regulatory T-cells [Tregs]) in Adolescents with Recent Onset Type 1 Diabetes Mellitus (T1DM)
16-19038OPIATE WITHDRAWAL RESPONSES TO INTRANASAL NALOXONE AS AN INDEX OF ALTERED ENDOGENOUS OPIOID ACTIVITY AMONG INDIVIDUALS WITH OBESITY: A FEASIBILITY AND EFFICACY STUDY
16-19120Fructose, de novo lipogenesis, and liver kinetics
16-19220PERSEUS: A Phase 2 Proof of Concept Study Investigating the Preliminary Efficacy and Safety of Cenicriviroc in Adult Subjects with Primary Sclerosing Cholangitis (PSC)
16-19342Ultra DXA: Accurate and precise quantitative multi-compartment body composition
16-19371The Impact of Early Medical Treatment in Transgender Youth
16-19381Safety and efficacy of ingenol mebutate gel 0.015% for treatment of actinic keratosis on the face in solid organ transplant recipients
16-19454Tailored Antiplatelet Initiation to Lessen Outcomes Due to Decreased Clopidogrel Response after Percutaneous Coronary Intervention: TAILOR-PCI
16-19462Investigating T cell phenotypes, levels of HIV persistence, and mechanisms of transcriptional control in the blood, cervix, endometrium, liver, and multiple gut sites of ART-treated women
16-19497Macular Edema Ranibizumab v. intravitreal anti-inflammatory Therapy Trial
16-19508TAU IMAGING WITH 18F-AV-1451 IN HEALTHY AGING
16-19516Exploring the Urinary Microbiome in Patients with Genitourinary Lichen Sclerosis
16-19537 Research on Expecting Moms and Sleep Therapy
16-19542Improving Preterm Infant Outcomes with Family Integrated Care and Mobile Technology
16-19688Mindfulness Training to Improve Mental Health, Stress and Performance in Physicians
16-19705Ferumoxytol-enhanced Cardiovascular MRI
16-19770Clinical and Biological Characteristics of Hidradenitis Suppurativa
16-19786An Osseointegrated Transhumeral Prosthesis For Transhumeral Amputees; a Prospective Cohort Study
16-19844Adversity and Health: Mapping a Road to Advantaged Educational and Health Outcomes in Diverse Children and Their Caregivers - A Novel Collaboration between DiverseCity and the NURTURE Center, UCSF Cardiology.
16-19931Imaging Biomarkers of Decision Making and Neuropsychiatric Disease
16-19935THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders.
16-20005I-SCAN for detection of sessile serrated adenomas/polyps
16-20016Patient-Centered Models of HCV Care for People who Inject Drugs
16-20036Comparison of Two Ridge Preservation Techniques with and without Primary Soft Tissue Closure: A Multi-Center Controlled Clinical Trial
16-20051International Randomized Trial to Evaluate the Effectiveness of the Portable Organ Care System (OCS™) Liver for Preserving and Assessing Donor Livers for Transplantation (OCS Liver PROTECT Trial)
16-20066Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis
16-20109Transcranial Direct Current Stimulation (tDCS) as a Treatment for Acute Fear
16-20146A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection
16-20163Short term group treatments for dementia caregivers with depression symptoms
16-20196Progression and etiology of cortical porosity in diabetic bone disease
16-20210Virtual Reality Vision Tests
16-20229Effects of acclimatization to high altitude on oxygenation and gene expression
16-20251TRIUMPH Collaborative (Trans Research-Informed communities United in Mobilization for the Prevention of HIV)
16-20284Cortical recordings to evaluate anxiety, depression and impulsivity in Parkinson's Disease patients
16-20296Validation of Novel Non-invasive Continuous Blood Pressure Measurement
16-20299Developing new models of the nevus to melanoma transformation
16-20339The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community
16-20346Advancing the multimodal pathway: Investigating the use of sleep and zolpidem in the recovery after shoulder arthroplasty
16-20351Novel Strategies for Cardiovascular Risk Reduction in Adults with Polycystic Kidney Disease
16-20360The effects of intranasal oxytocin on mixed HIV sero-status, methamphetamine-using men who have sex with men
16-20374Effect of voltage on electronic cigarette aerosol deposition
16-20375Predictors of time to viremia with an analytic treatment interruption
16-20376A Phase 1b, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of GS-9620 in Antiretroviral Treated HIV-1 Infected Controllers
16-20442An observational study to explore the vibrations and sounds of the body that occur with each heartbeat
16-20449The Validity of Hand-Held Ultrasound Evaluation of Rotator Cuff Pathology
16-20466Effect of Oral Iron Therapy on Erythrocyte Protoporphyrin Levels in the Erythropoietic Protoporphyrias
16-20470A PROSPECTIVE PILOT STUDY TO EVALUATE THE FEASIBILITY OF CONDUCTING REMOTE PATIENT MONITORING WITH THE USE OF DIGITAL TECHNOLOGY IN PATIENTS WITH MULTIPLE SCLEROSIS
16-20492HOME Study: Evaluation of a combination support package to increase uptake of Pre-exposure Prophylaxis and HIV/STI testing among young Black and Latino MSM in the San Francisco Bay Area.
16-20505COACH-MS: An Innovative First-in-Kind Randomized Controlled Pilot Clinical Trial Testing Proactive vs Reactive Management of a Symptom Triad in Multiple Sclerosis
16-20523The effect of lipoic acid natural supplement on cystine stone formation
16-20524Safety and Efficacy of Embozene® Microspheres for Uterine Fibroid Embolization Compared to Embosphere® Microspheres for Symptomatic Relief from Uterine Fibroids
16-20545An Open-Label Extension Study of Volanesorsen Administered Subcutaneously to Patients with Familial Chylomicronemia Syndrome (FCS)
16-20568A phase 1 clinical trial to evaluate the immunogenicity of AIDSVAX B/E bivalent gp120 vaccine and MVA/HIV62B in healthy, HIV-1 uninfected adult participants who previously received MVA/HIV62B in DNA/MVA or MVA/MVA regimens in HVTN 205
16-20591OPTIMAL DIAGNOSIS AND MANAGEMENT OF BACTERIAL KERATITIS
16-20684Transcranial Magnetic Stimulation for Therapeutic Applications
16-20685The use of fine needle aspiration of the inguinal lymph nodes to support HIV pathogenesis studies
16-20703A phase III, randomised, open-label, comparative safety and efficacy trial of intravenous iron isomaltoside (Monofer®) and iron sucrose in subjects with iron deficiency anaemia and non-dialysis-dependent chronic kidney disease
16-20723Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)
16-20726Targeted Neuroplasticity Training: peripheral nerve stimulation to facilitate language learning
16-20740Plasticity in Recovery from Surgery: The Effects of Exercise "Prehabilitation on Cognitive and Functional Recovery after Shoulder Replacement Surgery in Older Adults
16-20761The Inter-kingdom Gut Microbiota Composition in Obese Patients Undergoing Bariatric Surgery: Associations with Post-Surgical Outcomes
16-20768Testing of advanced MR imaging techniques to evaluate liver injury
16-20788Potential Use of Rotational Thromboelastometry to Explore Hemostatic Abnormalities in Patients with Acute Liver Failure (ALF) or Acute Liver Injury (ALI)
16-20814A Randomized Controlled Trial Evaluating the Effectiveness of a Topical Form of High Frequency Neuromodulation for Treatment of Chronic Low Back Pain.
16-20920A5345: Identification of Biomarkers to Predict Time to Plasma HIV RNA Rebound and Post-Treatment Viral Control during an Intensively Monitored Pause
16-20936Complex sound perception in MED-EL cochlear implant users.
16-20978Pilot to Examine Risk and Feasibility of Remote Management of BP from CKD through ESRD
16-21018Arterial Imaging of Inflammation and Resolution after Endovascular Surgery
16-21020A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects with Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension
16-21044Efficacy and safety of SAR156597 in the treatment of diffuse cutaneous Systemic Sclerosis (dcSSc): A randomized, double-blind, placebo-controlled, 24-week, proof of concept study
16-21062The Traumatic Brain Injury: Friend Controls Study; leveraging the infrastructure of Transforming Research and Clinical Knowledge in Traumatic Brain Injury: and funded by the TBI Endpoints Development (TED) Initiative
16-21092A randomized, parallel-group, placebo-controlled, double-blind Phase 1/2a study in healthy HIV-uninfected adults to assess safety/tolerability and immunogenicity of 2 different prime/boost regimens: priming with tetravalent Ad26.Mos4.HIV and boosting with tetravalent Ad26.Mos4.HIV and either Clade C gp140 plus adjuvant OR a combination of Mosaic and Clade C gp140 plus adjuvant
16-21140Multi-center, open-label, uncontrolled study to assess contraceptive efficacy and safety of Mirena during extended use beyond 5 years in women 18 to 35 years of age including a subgroup evaluation of treatment effect on heavy menstrual bleeding
16-21211More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
16-21226An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion using a Posterior Trajectory into the Putamen of Participants with Parkinson s Disease with Fluctuating Responses to Levodopa
16-21273Sperm Selection by Microfluidic Separation Improves Embryo Quality in Patients with a History of Poor Embryo Quality
16-21323Machine learning to distinguish HAND from Alzheimer's disease in HIV over age 60
16-21350Biomarkers for Acute Stroke Etiology
16-21356A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease
16081A Phase 1/1b, Open-Label, Dose-Escalation and Expansion Study of Entrectinib (RXDX-101) in Children and Adolescents with Recurrent or Refractory Solid Tumors and Primary CNS Tumors, with or without TRK, ROS1, or ALK Fusions
160816PNOC009: A Phase I and Early Efficacy Study of Convection Enhanced Delivery of Irinotecan Liposome Injection Using Real Time Imaging with Gadolinium in Children with Diffuse Intrinsic Pontine Glioma
160821Phase 1 Study of Pazopanib in Combination with Irinotecan and Temozolomide (PAZIT) for Children and Young Adults with Relapsed or Refractory Sarcoma
160823Multi-center, open-label randomized study of single or double myeloablative cord blood transplantation with or without infusion of off–the-shelf ex vivo expanded cryopreserved cord blood progenitor cells in patients with hematologic malignancies
160829Phase 1 Trial of CUDC-907 in Children and Young Adults with Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
160830Matched Targeted Therapy (MTT) Recommendation for Patients with Recurrent, Refractory, or High Risk Leukemias
161010Emergency Use of Enzastaurin to Treat Recurrent Glioblastoma
161019Ivy Foundation Early Phase Clinical Trials Consortium: A Phase 2 Study of Abemaciclib in Recurrent Glioblastoma
161021Vigilant ObservatIon of GlIadeL WAfer ImplaNT (VIGILANT) Registry: A Multicenter, Observational Registry to Collect Information on the Safety and Effectiveness of Gliadel Wafer (Carmustine Implant) Used in Usual Medical Practice
16104A Randomized Phase 3 Single Blind Study of Temozolomide plus Radiation Therapy combined with Nivolumab or Placebo in Newly Diagnosed Adult Subjects with MGMT-Methylated (tumor O6-methylguanine DNA methyltransferase) Glioblastoma
16106Feasibility and Efficacy of an iPad-Based Cognitive Rehabilitation Program in Brain Tumor Patients
16107A Phase 2/3 Randomized, Open Label Study of Toca 511, a Retroviral Replicating Vector, Combined with Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
16109A Phase 2, Multicenter Study of Tesevatinib Monotherapy in Patients with Recurrent Glioblastoma
16201Pharmacodynamic Effects and Predictive Biomarkers of JAK/STAT Inhibition with Ruxolitinib in Operable Head and Neck Cancer: A Window Trial
162010Nivolumab in Combination with Chemoradiation for Patients with Stage II-IVB Nasopharyngeal Carcinoma, A Phase II Study with Correlative Biomarkers
16202Employing Humanized NSG (hu-NSG) Mice for Testing Immune Modulators in Human Head and Neck Squamous Cell Carcinoma Xenografts
16203A Two-Arm, Open-label, Randomized Phase III Study of Pembrolizumab (MK-3475) Monotherapy versus Standard Chemotherapy in Platinum Pre-treated, Recurrent or Metastatic Nasopharyngeal Cancer (NPC) (Keynote-122)
16205A Phase 1b/2, Open-Label, Multicentre Study Assessing the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of MEDI4736 in Combination With AZD9150 or AZD5069 in Patients With Advanced Solid Malignancies and Subsequently Comparing AZD9150 and AZD5069 Both as Monotherapy and in Combination With MEDI4736 as Second Line Treatment in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
16251A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Protein Expression in Diffuse Large B-Cell Lymphoma
16252Long Term Follow-Up of Patients Exposed to Lentiviral-Based CD19 directed CART Cell Therapy CCTL019A2205B
16253End-of-Life Care for Hematopoietic Stem Cell Transplant Recipients
16258Karius Sequencing Test in Diagnosis of Infection in Stem Cell Transplant Patients Over Time
16259Retrospective Study Correlating Multiple Myeloma Minimal Residual Disease by Clonoseq with Patient Outcomes
16401Assessing the Predictive Capability of Cell-Free DNA as a Screening Tool for Ovarian Cancer in Women with Inherited BRCA Mutations
16451A Study of Safety, Tolerability, and Clinical Activity of MEDI4736 and Tremelimumab Administered as Monotherapy and in Combination to Subjects with Unresectable Hepatocellular Carcinoma
164511Survivor Choices for Eating and Drinking (SUCCEED) – Colorectal Cancer
164512Multi-Center Chart Review Study in the US to Examine Treatment Patterns and Associated Outcomes among Patients with Advanced Neuroendocrine Tumors (NET) of Gastrointestinal (GI) Origin
164513Multi-Center Chart Review Study in the US to Examine Treatment Patterns and Associated Outcomes among Patients with Advanced Neuroendocrine Tumors (NET) of Lung Origin
164518A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) in Combination with nab-Paclitaxel Plus Gemcitabine Compared with Placebo Plus nab-Paclitaxel and Gemcitabine in Subjects with Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma
164519Circulating Tumor Derived Cell-free DNA as a Novel Biomarker to Predict Recurrence of Colorectal Cancer
16452Phase I/II Study of TAS-102 and Radioembolization with 90Y Resin Microspheres for Chemo-Refractory Colorectal Hepatic Metastases
164520Sharing Clinical and Genomic Data for Cancer Research
16455Expanded Access Protocol for Therapeutic Use of 177Lu-DOTA0-Tyr3-Octreotate in Patients with Inoperable, Somatostatin Receptor Positive, Midgut Carcinoid Tumors, Progressive Under Somatostatin Analogue Therapy
16459A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects with Resected Esophageal, or Gastroesophageal Junction Cancer
16527A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations
165511Targeting Adaptive Pathways in Abiraterone and Enzalutamide Refractory Intermediate Atypical Carcinoma
165513A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
165514A PrOspective Phase 2/3 Multi-Center, Open-Label Study of 18F-DCFPyL PET/CT Imaging in Patients with PRostate Cancer: Examination of Diagnostic AccuracY (OSPREY)
16552A Phase 1b, Open-Label Study of the Safety and Tolerability of Atezolizumab in Combination with Radium-223 Dichloride in Patients with Castrate-Resistant Prostate Cancer who have Progressed Following Treatment with an Androgen Pathway Inhibitor
16553Metastatic Standard Treatment Long Term Outcomes Evaluation
16557Phase 2 open label study of pembrolizumab in patients with metastatic castration resistant prostate cancer (mCRPC) with or without DNA damage repair defects
16559Gallium-68 PSMA-11 PET in intermediate to high-risk preprostatectomy patients
166510Biomarkers of Pulmonary and Renal Fibrosis
166511Phase II Trial of TG4010 plus Nivolumab in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)
166512A Phase I/II study of Ceritinib + Trametinib in Patients with Advanced ALK-Positive NSCLC
166513MOLECULAR ASSAY, RISK-STRATIFICATION ADJUVANT CHEMOTHERAPY OUTCOMES STUDY
166518A Parallel Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Advanced or Metastatic Non-Small Cell Lung Cancer
166519Prospective genomic analysis of cell-free tumor DNA in advanced EGFR-mutant lung cancer patients treated with an EGFR TKI
166520PembroX: Enhancing the Immunogenicity of Non-Small Cell Lung Cancer with Pembrolizumab +/- Stereotactic Radiotherapy Delivered in the Preoperative Window, A Randomized Phase II Study with Correlative Biomarkers
166521Phase II trial to evaluate trametinib in patients with advanced NF1-mutant non-small cell lung cancer
16659Biomarkers of Treatment Response in Esophageal Cancer
167010Phase I Study of MK-3475 (Pembrolizumab) in Patients with Human Immunodeficiency Virus (HIV) and Relapsed/Refractory or Disseminated Malignant Neoplasm
167012An Open-label, Phase IB study of NEO-PV-01 + Adjuvant with Nivolumab in Patients with Melanoma, Non-Small Cell Lung Carcinoma or Transitional Cell Carcinoma of the Bladder
16702A Phase 1/1b, Open-Label, Multicenter, Repeat-Dose, Dose-Selection Study of CPI-444 as Single Agent and in Combination with Atezolizumab in Patients with Selected Incurable Cancers
16704Testing the Ability of Pembrolizumab to Alter the Tumor Immune MicroEnvironment (TIME) of High Risk DCIS
16706A Phase 1, First-in-Human, Open Label, Dose Escalation Study of MGD009, a Humanized B7-H3 x CD3 Dual-Affinity Re-Targeting (DART®) Protein in Patients with Unresectable or Metastatic B7-H3-Expressing Neoplasms and Neoplasms whose Vasculature Expresses B7-H3
16707A Phase 1, Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered CA-170 in Patients with Advanced Tumors and Lymphomas
16709Functional Imaging of T-cell Activation with [18F]F-AraG in Bladder Cancer Patients Receiving Neoadjuvant or Standard of Care Atezolizumab
16751Fertility Preservation using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
167510Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
167514An Open Label Study to Characterize the Incidence and Severity of Diarrhea in Patients with Early Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab and Neratinib followed by Neratinib Monotherapy, and Intensive Anti-diarrhea Prophylaxis
16752The WISDOM Study (Women Informed to Screen Depending on Measures of Risk)
16755Imaging Spectrum of Breast Cancer Metastases and Potential Metastatic Pathways
16757A Randomized Phase III Trial of Palbociclib with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer
16758A Phase 1b trial of the cyclin-dependent kinase inhibitor dinaciclib in combination with pembrolizumab in patients with advanced breast cancer and assessment of MYC oncogene overexpression
16759Second Opinions and the Treatment Gradient Experienced by African American Breast Cancer Patients: An Exploratory Study
16801Developing an Integrative Ayurvedic Intervention for Breast Cancer Survivorship
16802Treatment of breast cancer-related LE with a negative pressure device: a pilot randomized controlled study
16855A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Epacadostat in Combination With Durvalumab in Subjects With Selected Advanced Solid Tumors
16856Health eHeart-CardioOncology and Immunotherapy Pilot study (HeH-COIP)
16871Retrospective Analysis of Neo-adjuvant Chemotherapy in Pleomorphic Soft Tissue Sarcoma Patients Treated at UCSF
169513An Open-Label, Phase 1b, Multi-Arm Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination with Standard of Care Immune Checkpoint Inhibitors in Patients with Advanced Melanoma
169516A phase I/II, multicenter, open-label study of MAK683 in adult patients with advanced malignancies
169517A Phase I Dose Escalation Study, with Cohort Expansion, to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of AbGn-107 Therapy in Patients with Chemo-refractory Locally Advanced, Recurrent, or Metastatic Gastric, Colorectal, or Pancreatic Cancer
169519A Phase 2 Study of Cediranib in Combination with Olaparib in Advanced Solid Tumors
16952A Phase 1 Safety and Tolerability Study of ZEN003694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer
169521Combination therapy of Rucaparib and Irinotecan in cancers with DNA repair mutations
169522A First-in-Human Phase 1/2a Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of FF-10101-01 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia
169524A Pilot Study of Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas
16953A Phase Ib/II Multi-Arm Study with Venetoclax in Combination with Cobimetinib and Venetoclax in Combination with Idasanutlin in Patients Aged >= 60 Years with Relapsed or Refractory Acute Myeloid Leukemia who are not Eligible for Cytotoxic Therapy
16954Phase 1/2 Study of CORT125134 in Combination with Nab-paclitaxel in Patients with Solid Tumors
16957Phase 1/2 Clinical Study of Niraparib in Combination with Pembrolizumab in Patients with Advanced or Metastatic Triple-Negative Breast Cancer and in Patients with Recurrent Ovarian Cancer
169810Retrospective Analysis of Radiotherapy Techniques and Outcomes
16983Biospecimen Acquisition Protocol for Analysis of Biomarkers in Cancers
17-21497Contrast-enhanced ultrasound versus CT scan for kidney stone patient management
17-21502Treatment with Lorcaserin for Cocaine Use: The TLC Study
17-21552Bone Quality and Marrow Adiposity in Subjects with HIV
17-21580Connectomic imaging in familial and sporadic frontotemporal degeneration (Connectome)
17-21611Intervention Study In Overweight Patients with COPD
17-21645A Pilot Study to Assess Sustained Oxygen Delivery by Simple Oxygen Mask on Central Submacular Thickness in Patients with Exudative Age-Related Macular Degeneration
17-21672Role of the cartilage endplate in spinal disc degeneration
17-21695Women's Lifestyle Balance Program
17-21701A Repository of Healthy-Control Stool and Blood for Anti-Commensal Antibody Research
17-21815Immunogenicity of Nonavalent HPV Vaccine Administered Prior To Living Donor Renal Transplantation in Adult Women: A Prospective, Single-Arm, Multi-Center Clinical Trial
17-21846Measuring cardiac head impulse to detect acute large vessel ischemic stroke
17-21905The effect of SLC19A3 inhibition on the pharmacokinetics of thiamine
17-21951Determination of Normal Values and Optimization of Hyperpolarized MRI Techniques in the Human Body.
17-22014Alternative provision of medication abortion via pharmacy dispensing
17-22051Discovery in Unexplained and Rare Diseases
17-22074Prospective Evaluation of Chronic Hepatitis E in the Transplant Setting
17-22075Cardiovascular Inflammation Reduction Trial (CIRT): A randomized, double-blind, placebo-controlled, event-driven trial of weekly low-dose methotrexate (LDM) in the prevention of cardiovascular events among stable coronary artery disease patients with type 2 diabetes or metabolic syndrome
17-22110Study of time-restricted eating on weight loss. A randomized controlled trial of the effects of time-restricted eating on weight loss in obese subjects
17-22141Examination of PTSD, Anxiety and Depression in Parents and Children with Pediatric Arterial Ischemic Stroke and Association with Stroke Outcome
17-22161Inflammatory skin disease
17-22237Cardiovascular Inflammation Reduction Trial (CIRT) Inflammation Imaging Study
17-22256Rate of Progression in USH2A Related Retinal Degeneration (RUSH2A)
17-22287BONE MARROW ASPIRATION STUDY
17-22295Choroidal vascular compliance in postmenopausal women
17-22314Novel imaging and endothelial biomarkers of small vessel cerebrovascular disease
17-22331Aneuploidy rates and morphokinetic parameters in sibling embryos cultured in distinct culture media
17-22393One Stage versus Two Stage For Periprosthetic Hip and Knee Infection
17-22420Clinical Utility of Prenatal Whole Exome Sequencing
17-22429Randomized, Double-Blind, Phase 3B Trial to Evaluate the Safety and Efficacy of 2 Treatment Regimens of Aztreonam 75 mg Powder and Solvent for Nebulizer Solution / Aztreonam for Inhalation Solution (AZLI) in Pediatric Subjects with Cystic Fibrosis (CF) and New Onset Respiratory Tract Pseudomonas aeruginosa (PA) Infection/Colonization
17-22438Impact of Somatosensory Deficits on Upper Limb Motor Learning in Stroke Subjects
17-22443Trial to Assess the Agreement of Measures Derived From a Home Sleep Monitoring System And Conventional Polysomnography
17-22474Writing and Interview Tasks Study: The effect of writing on reactivity and health
17-22535Retinal eye-tracking and targeted acuity tasks to monitor sports concussion recovery
17-22615Primary pain generator identification in patients with axial facetogenic low back pain using 18(F)-NaF PET/MRI
17-22618PRIME Study (PRebiotic to IMprovE Calcium Absorption)
17-22671Insulin Resistance and Cognitive Function in Polycystic Ovary Syndrome (PCOS)
17-22743Echocardiography Examination in the Women s Interagency HIV Study (WIHS)
17-22758Pilot to Examine Risk and Feasibility of Remote Management of BP from Childhood into Early Adulthood (PERFORMANCE II)
17-22789ROLE OF HERPESVIRUSES AS A CAUSATIVE FACTOR IN ACUTE APICAL ABSCESS
17-22790HCV cure and Kidney Health: A prospective, observational cohort study of HCV Genotype 1 and 4 infected adults with and without HIV infection
17-22800Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
17-22885An Open-Label, Multi-Site Phase 2 Study of the Safety and Effect of Manualized MDMA-Assisted Psychotherapy for the Treatment of Severe Posttraumatic Stress Disorder
17-23008Fibroblast specific inhibition of LOXL2 and TGFbeta1 signaling in patients with pulmonary fibrosis.
17-23066Knee and Patellofemoral Overload and Articular Cartilage Injuries: The advanced Imaging Protocol Study
17-23111PulseRider Aneurysm Neck Reconstruction Device
17-231143D Printed Cast vs Synthetic Cast in Non-operative Distal Radius Fractures
17-23142Cigarette Harm Reduction With Scheduled Electronic Cigarette Use
17-23143Monitoring of Huntington's Disease with 7T MRI
17-23188U01: Clinical Trial Readiness for SCA1 and SCA3
17-23253Comparison of Flat-Panel Computed Tomography with Conventional CT Imaging for Bleed Detection in Cerebrovascular Disease
17-23293Genes, Brains and Decision-Making
17-23297The Impact of Psychological Stress on Patients with non-Infectious Uveitis
17-23310Pre- and Post-Operative Hip Joint Bone Metabolism and Mechanics in FAIS Patients
17-23356A Pilot Trial of Using Pre-Transplant Risk Stratification and Prophylactic Defibrotide to Prevent Serious Thrombotic Microangiopathy in High-Risk Hematopoietic Stem Cell Transplant Patients
17-23361Longitudinal Evaluation of Ovarian Aging and Cardiovascular Risk
17-23432A PROSPECTIVE STUDY OF T CELL IMMUNE-PHENOTYPE AND DISEASE OUTCOME IN PULMONARY SARCOIDOSIS
17-23469Conventional Computed Tomography (CT) vs. Flat Panel CT for assessment of cerebral blood flow (CBF) in acute ischemic stroke (AIS)
17-23474Treatments Against RA and Effect on FDG PET-CT: The TARGET Trial
17-23516Immunogenetic profiling of Goeckerman Therapy in the treatment of Psoriasis Vulgaris
17-23710Using ERG to diagnose and evaluate glaucoma
17-23832Neural Signatures of pain relief from spinal cord stimulation
17-23880Confounding influence of measuring intraocular pressure atop a scleral contact lens on accurate scleral tonometry
17-23965Short-Term Cardiovascular Effects of E-Cigarettes: Influence of Device Power
17-24046SAFETY, IMMUNOGENICITY AND ANTI-RESERVOIR ACTIVITY OF AN ELECTROPORATION-ADMINISTERED HIV DNA VACCINE ENCODING GAG, POL AND ENV PROTEINS WITH IL-12 PLASMID IN HIV-INFECTED ADULTS ON ANTIRETROVIRAL THERAPY
17-24206Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation with Histone Deacetylase Inhibitors
17-24240An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed with Early-Onset Idiopathic Bilateral Cataracts
170817PNOC015: An Open Label Single Arm Phase I/II study of MTX110 delivered by convection-enhanced delivery (CED) in patients with diffuse intrinsic pontine glioma (DIPG) previously treated with external beam radiation therapy
170819A Phase I Study of Ad-RTS-hIL-12, an Inducible Adenoviral Vector Engineered to Express hIL-12 in the Presence of the Activator Ligand Veledimex in Pediatric Brain Tumor Subjects
171016A Multicenter Phase 1, Open-Label Study of DCC-2618 to Assess Safety, Tolerability, Efficacy, and Pharmacokinetics in Patients with Advanced Malignancies
17107A Proof-of-Concept, Pilot Study of Pembrolizumab (MK-3475) in Patients with Recurrent Malignant Glioma with a Hypermutator Phenotype
17109Ivy Foundation Early Phase Clinical Trials Consortium BioTarget Protocol
172016Gallium-68 Prostate Specific Membrane Antigen (68Ga-PSMA) PET for Imaging of Thyroid Cancer: A Feasibility Study
17204A Phase 1b/2, Open-label, Multicenter, Dose-escalation and Expansion Trial of Intratumoral SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
17209A Randomized Phase III study of pembrolizumab given concomitantly with chemoradiation and as maintenance therapy versus chemoradiation alone in subjects with locally advanced head and neck squamous cell carcinoma (KEYNOTE-412)
17254A Randomized, Double-Blind Phase 3 Study of Ibrutinib in Combination with Corticosteroids versus Placebo in Combination with Corticosteroids in Subjects with New Onset Chronic Graft Versus Host Disease (cGVHD)
17401ARIEL4 (Assessment of Rucaparib In Ovarian CancEr TriaL): A Phase 3 Multicenter, Randomized Study of Rucaparib versus Chemotherapy in Patients with Relapsed, BRCA-Mutant, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
174017Gallium-68 Prostate Specific Membrane Antigen for Ovarian Cancer: A Pilot Feasibility Study
17403A Phase III, Multi-center, Randomized Study of Atezolizumab versus Placebo Administered in Combination with Paclitaxel, Carboplatin, and Bevacizumab to Patients with Newly Diagnosed Stage III or State IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
17404A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors
17451A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled Study of AG-120 in Previously-treated Subjects with Nonresectable or Metastatic Cholangiocarcinoma with an IDH1 Mutation
174512A PHASE Ib/II, OPEN-LABEL, MULTICENTER, RANDOMIZED UMBRELLA STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE IMMUNOTHERAPY-BASED TREATMENT COMBINATIONS IN PATIENTS WITH METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA (MORPHEUS-PANCREATIC CANCER)
174517Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab in Microsatellite Stable Metastatic Colorectal Cancer
174518Gallium-68 Prostate Specific Membrane Antigen (68Ga-PSMA) PET in Hepatocellular Carcinoma (HCC); a feasibility study
174523Multicenter Pilot Study of the Safety, Efficacy, and Immune Cell Profiling in Advanced Hepatocellular Carcinoma (HCC) Patients Treated with the Combination of Sorafenib plus Nivolumab as First-Line of Systemic Therapy
174525Self-Monitoring and Reminder Texts for Physical Activity After Cancer II (Smart Pace II)
174528A Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Metastatic Colorectal Cancers
174534Being Present 2.0: Web-based Mindfulness Meditation for Gastrointestinal Cancer Patients and Caregivers
17455Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor
17457A Dose-Finding Phase 1 Study Of Tas-120 In Patients With Advanced Solid Tumors With Or Without Fibroblast Growth Factor/Receptor (Fgf/Fgfr)-Related Abnormalities Followed By A Phase 2 Study In Patients With Advanced Solid Tumors With Fgf/Fgfr-Related Abnormalities
17459Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver (RETNET): A phase 2 randomized multicenter trial to compare hepatic progression-free survival following bland embolization, lipiodol chemoembolization, and drug-eluting bead chemoembolization of neuroendocrine liver metastases
17527CTT1057, a Small Molecular Inhibitor of Prostate Specific Membrane Antigen (PSMA), as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma: A Pilot Study
175511A Randomized, Double-blind, Placebo-controlled Phase 3 Study of JNJ-56021927 in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Receiving Treatment with Primary Radiation Therapy
175513A Randomized Clinical Trial of Lifestyle Interventions using Digital Health Technology and Coaching Versus Usual Care among Men with Prostate Cancer II (Prostate 8 - II)
175518Gallium-68 PSMA-11 PET in patients with biochemical recurrence
17556A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician s Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency
17651Randomized, Double-Blind, Phase 2/3 Study in Subjects with Malignant Pleural Mesothelioma with Low Argininosuccinate Synthetase 1 Expression to Assess ADI-PEG 20 with Pemetrexed and Cisplatin (ATOMIC-Meso Phase 2/3 Study)
176518A Phase 2 Study of Poziotinib in Patients with Non-Small Cell Lung Cancer, Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation (POZITIVE20-1)
17652An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
17701A Pilot Study of APX005M in Combination with Concurrent Chemoradiation as Neoadjuvant Therapy for Resectable Esophageal and Gastroesophageal Junction Cancers
177016A PHASE 2, MULTICENTER STUDY TO DETERMINE THE EFFICACY AND SAFETY OF BB2121 IN SUBJECTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA
17704A Phase 1 Study of bb21217, an anti-BCMA CAR T Cell Drug Product, in Relapsed and/or Refractory Multiple Myeloma
17705A pilot study of pembrolizumab and liver-directed therapy for patients with well-differentiated neuroendocrine tumors and symptomatic and/or progressive liver metastases
17707A Randomized, Phase 2 Study of Ipilimumab vs Ipilimumab plus Nivolumab in Patients with Stage III-IV Melanoma Who Have Progressed or Relapsed on PD-1 Inhibitor Therapy
17709Open-label, Multicenter, Phase 1b/2 Clinical Study to Evaluate the Safety and Efficacy of CD40 Agonistic Monoclonal Antibody (APX005M) Administered Together with Gemcitabine and nab-Paclitaxel with or without PD-1 Blocking Antibody (Nivolumab) in Patients with Previously Untreated Metastatic Pancreatic Adenocarcinoma
177514A phase 1, open-label, dose-escalation study to evaluate the safety and tolerability of SGN-LIV1A in patients with LIV-1-positive metastatic breast cancer
17752A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 Versus Treatment of Physician's Choice (TPC) in Patients with Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With Anthracycline, A Taxane, and Capecitabine
177525A Phase II, Multicenter, open-label, two-cohort, non-comparative study to assess the efficacy and safety of alpelisib plus fulvestrant or letrozole in patients with PIK3CA mutant, hormone receptor (HR) positive, HER2-negative advanced breast cancer (aBC), who have progressed on or after CDK4/6 inhibitor treatment
177528A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy after Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer
17854Prostaglandin Inhibition and PD-1/CTLA4 blockade in Melanoma
17951A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF ORAL ENTRECTINIB (RXDX-101) IN ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC CANCER CONFIRMED TO BE POSITIVE FOR NTRK1, NTRK2, NTRK3, ROS1, OR ALK MOLECULAR ALTERATIONS
17953A Phase 1 Study Evaluating the Safety, Pharmacology and Preliminary Activity of MM-310 in Patients with Solid Tumors
18-24317Operative versus Non-Operative Treatment for Atraumatic Rotator Cuff Tears: A Multicenter Randomized Controlled Pragmatic Trial
18-24366Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
18-24547A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder
201585A Phase III, randomized, multicenter, parallel-group, non-inferiority, open-label study evaluating the efficacy, safety, and tolerability of switching to long-acting cabotegravir plus long-acting rilpivirine from current INI- NNRTI-, or PI-based antiretroviral regimen in HIV-1-infected adults who are virologically suppressed
207966A Phase IIIb, Randomized, Multicenter, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every 8 Weeks or Every 4 Weeks in HIV-1-infected Adults who are Virologically Suppressed
221AD301A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects with Early Alzheimer's Disease
251PP201A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients with Progressive Supranuclear Palsy Who Participated in Study CN002003
270-902A Prospective Non-Interventional Study of Bleeding Episodes, Factor VIII Infusions, and Patient-Reported Outcomes in Individuals with Severe Hemophilia A
3152-301-002A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis
402-C-1603A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients with Alport Syndrome
4RTNI-24-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
7163-CL-3201A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de novo Kidney Transplant Recipients
747-304A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis
747303-REGENERATEA Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis
992FD001A Study to Model Rates of Change on Neuropsychological Test Measures in Subjects Diagnosed With Behavioral Variant Frontotemporal Dementia and Healthy Subjects
A5128Plan for Obtaining Informed Consent to use Stored Human Biological Materials (HBM) for Currently Unspecified Analysis.
A5302BioBank for Surrogate Marker Research for TB (B-SMART)
A5320Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
A5321Decay of HIV-1 Reservoirs in Subjects on Long-Term Antiretroviral Therapy: The ACTG HIV Reservoirs Cohort (AHRC) Study
A5322Long-term Follow-up of Older HIV-infected Adults in the ACTG: Addressing Issues of Aging, HIV Infection and Inflammation
A5332Randomized Trial to Prevent Vascular Events in HIV REPRIEVE (A5332)
A5341SSize and Decay of HIV-1 Reservoirs in Tissues and Cerebrospinal Fluid in Participants on Long-Term Antiretroviral Therapy: A Substudy of A5321, the ACTG HIV Reservoirs Cohort (AHRC) Study
A5347SAnatomic Reservoir Substudy of A5345 (Biomarkers to Predict HIV-1 Rebound During IMAP)
A5349Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial
AALL0932Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy)
AALL1131A Phase 3 Randomized Trial for Newly Diagnosed High Risk BLymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (IND#73789, NSC#732517) in Patients with Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
AALL1331Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
AALL1521A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway Mutant Acute Lymphoblastic Leukemia
AAML1331A Phase III Study for Patients with Newly Diagnosed Acute Promyelocytic Leukemia (APL) using Arsenic Trioxide and All- Trans Retinoic Acid
ABTC-1301Pilot Study of MLN0128 (TAK-228) in Preoperative Recurrent Glioblastoma (GBM) Patients
ABTC-1602Single-arm, Open-label Phase II Efficacy Study of First-in-class HIF2-Alpha Inhibitor, PT2385, for Patients with Recurrent Glioblastoma
ACEAllergen Challenge for Evoked Phenotypes in Asthma
ACL-AFA Multi-Center Feasibility Trial Establishing Imaging And Biochemical Technologies As Measures Of Knee Cartilage Composition Following Acute ACL Injury
ACNS0831Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 Years
AD-DUPIX-IMMImmunogenetic profiling of dupilumab for the treatment of atopic dermatitis
AD-YP-001A 12 Month, Pilot Clinical Trial of Monthly Young Healthy Male Donor Plasma Transfusions for Mild Cognitive Impairment (MCI) due to Alzheimer’s Disease or Alzheimer’s Disease Dementia
ADNI-DADNI Depression
ADVL1312A Phase 1/2 Study of AZD1775 (MK-1775, IND# 121422) in Combination with Oral Irinotecan in Children, Adolescents, and Young Adults with Relapsed or Refractory Solid Tumors
ADVL1322A Phase II Trial of Pazopanib NSC# 737754, IND# 65747 in Children with Refractory Solid Tumors
ADVL1412A Phase 1/2 Study of Nivolumab (IND#124729) in Children, Adolescents, and Young Adults with Recurrent or Refractory Solid Tumors as a Single Agent and in Combination with Ipilimumab
ADVL1416A Phase 1 Study of Ramucirumab, a Human Monoclonal Antibody Against the Vascular Endothelial Growth Factor-2 (VEGFR-2) Receptor in Children with Refractory Solid Tumors, Including CNS Tumors
ADVL1513A Phase 1 Study of Entinostat, an Oral Histone Deacetylase Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
ADVL1515A Phase 1 Study of LY2606368, a CHK1/2 Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors, Including CNS Tumors
AEWS1221-CIRBRandomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma
AI444046A Long-Term Follow-up Study of Subjects Who Participated in a Clinical Trial in Which Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Was Administered for the Treatment of Chronic Hepatitis C
AIN457AUSNC02TStem cells and the role of Secukinumab in the treatment of epidermal hyperproliferation in psoriasis.
ALE09A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
ALF-MBT13C-Methacetin Breath Test for the Prediction of Outcome in Acute Liver Failure
ALFSG-STOP-ALFMulticenter Group to Study Acute Liver Failure; A Phase 2a Study to Evaluate the Safety and Tolerability of OCR-002 (ornithine phenylacetate) in the Treatment of Patients with Acute Liver Failure/Severe Acute Liver Injury (STOP-ALF)
ALLIANCE-A011401Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
ALLIANCE-A051301A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation versus Placebo in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
ALLIANCE-A071401Phase II Trial of SMO/AKT/NF2 Inhibitors in Progressive Meningiomas with SMO/AKT/NF2 Mutations
ALLTOL-ITN063STALLTOL: A Prospective Cohort Study of Operationally Tolerant Allograft Recipients
ALN-AS1-002A Multicenter, Open-label Extension Study to Evaluate the Long-term Safety and Clinical Activity of Subcutaneously Administered ALN-AS1 in Patients with Acute Intermittent Porphyria who have Completed a Previous Clinical Study with ALN-AS1
ALN-AS1-NT-001A Natural History Study of Acute Hepatic Porphyria (AHP) Patients with Recurrent Attacks.
ALXN-M11-001An Observational, non-interventional, multicenter, multi-national study of patients with atypical hemolytic-uremic syndrome (aHUS Registry)
AMC-088A Randomized, Phase III Study of Intra-anal imiquimod 2.5% vs. Topical 5-fluorouracil 5% vs. Observation for the Treatment of High-grade Anal Squamous Intraepithelial Lesions in HIV-infected Men and Women
AMC-092A Multicenter Observational and Feasibility Study of Excision of Superficially Invasive Squamous Cell Carcinoma (SISCCA) of the Anal Canal and Perianus in HIV-Infected Persons
AMC-095A Phase I Study of Ipilimumab and Nivolumab in Advanced HIV Associated Solid Tumors with an Expansion Cohort in HIV Associated Solid Tumors
AMP-002A Randomized, Double-Blind, Active Comparator-Controlled, Crossover Study to Assess the Capacity of Delayed-Release Prednisone (RAYOS®) Compared to Immediate-Release Prednisone to Improve Fatigue and Control Morning Symptoms in Subjects with Generalized Systemic Lupus Erythematosus
ANHL12P1A Randomized Phase II study of Brentuximab Vedotin (NSC# 749710) and Crizotinib (NSC# 749005) in Patients with Newly Diagnosed Anaplastic Large Cell Lymphoma (ALCL) IND #117117
ANHL1522A Pilot Study of Rituximab (RTX) and Third Party Latent Membrane Protein (LMP)-specific Cytotoxic T-Lymphocytes (LMP-TC, IND # 17068) in Pediatric Solid Organ Recipients (SOT) with EBV-Positive CD20-Positive Post-Transplant Lymphoproliferative Disease (PTLD)
AOST1321Phase 2 Study of Denosumab (IND# 127430, NSC# 744010), a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma
APEC1621SCNCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
APG01A Phase I, Open-Label, Multicenter Trial Exploring the Safety and Tolerability of Autologous Polyclonal Regulatory T Cell Therapy in Adults with Active Pemphigus
APSS-44-00A Multicenter, Double-Blind, Randomized, Saline-Controlled Study of a Single, Intra-Articular Injection of Autologous Protein Solution in Patients with Knee Osteoarthritis
ARA08Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis (StopRA)
ARC003-AIMMUNEPEANUT ALLERGY ORAL IMMUNOTHERAPY STUDY OF AR101 FOR DESENSITIZATION IN CHILDREN AND ADULTS (THE PALISADE STUDY)
ARC004Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)
ARCADIAAtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke
ARISTAMulti-Institutional Randomized Controlled Trial evaluating use of Arista Absorbable Surgical Hemostatic Powder as an Intraoperative Adjunctive Hemostat in Anterolateral Thigh Donor Sites
ARRON-PEMPHIGUSA RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, ACTIVE-COMPARATOR, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RITUXIMAB VERSUS MMF IN PATIENTS WITH PEMPHIGUS VULGARIS
ARST1321Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754, IND# 118613)
ARST1431A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating with Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864, IND# 122782) in Patients with Intermediate Risk (IR) Rhabdomyosarcoma (RMS)
ARTFL8101Advancing the Research and Treatment of Frontotemporal Lobar Degeneration (ARTFL): Rare Diseases Clinical Research Network The Frontotemporal Lobar Degeneration Clinical Research Consortium: Research Projects 1 & 2
AS0005Multicenter, Open-Label (Part A) Followed by a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study (Part B) to Evaluate Maintenance of Remission in Subjects with Active Axial Spondyloarthritis (axSpA) Receiving Either Certolizumab Pegol 200mg Q2W or 200mg Q4W as Compared to Placebo
AS0006Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Certolizumab Pegol (CZP) in Subjects with Active Axial Spondyloarthritis (axSpA) without X-Ray Evidence of Ankylosing Spondylitis (AS) and Objective Signs of Inflammation
ATM-96814A Single-Center, Non-Randomized Study of the Safety and Efficacy of In Utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses with Alpha Thalassemia Major
AUTISM-BIOMARKERAssessment of Biochemical Pathways and Biomarker Discovery in Autism Spectrum Disorder (ASD)
AV-299-14-206A Phase 2, multicenter, randomized, double-blind study of ficlatuzumab plus erlotinib versus placebo plus erlotinib in subjects who have previously untreated metastatic, EGFR-mutated non-small cell lung cancer (NSCLC) and BDX004 Positive label.
BARD-APEXZZ Best African American Response to Asthma Drugs
BHV-4157A Phase IIb/III, Randomized, Double-blind, Placebo-controlled Trial of BHV-4157 in Adult Subjects with Spinocerebellar Ataxia
BIOGENSPARKA Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Subjects with Parkinson’s Disease
BLOCK-COPDBeta-Blockers for the Prevention of Acute Exacerbations of COPD
BMT-CTN-1401Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma with or without Vaccination with Dendritic Cell/Myeloma Fusions
BMT-CTN-1506A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Trial of the FLT3 Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients with FLT3/ITD AML
BN29552A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF CRENEZUMAB IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER S DISEASE
BN29553A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, EFFICACY AND SAFETY STUDY OF CRENEZUMAB IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER S DISEASE
BOLDAssessing kidney oxygenation by Magnetic Resonance Imaging (MRI)
BONEGRAFTYIELDComparing Yield of Autologous Bone Graft using Ultrasonic Scalpel with Conventional Techniques
BP39529A Randomized, Double-Blind, Placebo-Controlled, 52-Week Phase II Study to Evaluate the Efficacy of Intravenous RO7046015 (PRX002) in Participants with Early Parkinson s Disease with a 52-Week Blinded Extension (PASADENA)
BYDUREONA Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients with Type I Diabetes.
CAIN457AUS04TCharacterization of the response to secukinumab in plaque psoriasis using novel immunologic and genetic profiling
CAIN457K2340A randomized, partially-blinded, active-controlled multicenter study of secukinumab to demonstrate reduction of radiographic progression versus GP2017 (adalimumab biosimilar) at 104 weeks and to assess the long term safety, tolerability and efficacy up to 2 years in patients with active ankylosing spondylitis
CARBOXY-MASIMO-20140709Accuracy of detection of carboxyhemoglobin with pulse oximetry
CARBOXY-NONIN-20141015Accuracy of detection of carboxyhemoglobin with pulse oximetry
CCN016A multi-center, single-blind, randomized clinical trial to compare two copper IUDs:Mona Lisa NT Cu380 Mini and ParaGard
CDIFFFMTNatural History of Patients undergoing Fecal Microbial Transplantation for Recurrent Clostridium Difficile Infection
CENIC2P1Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace
CEREB-MESPERE-20140923Accuracy of cerebral oximeters with hypoxia and methemoglobin or carboxyhemoglobin
CEREBRAL-CASM09-20160315CASM09 - Accuracy of non-invasive measurement of hemoglobin concentration
CEREBRAL-CASM10-20160427Controlled Desaturation for Cerebral Oximetry
CEREBRAL-MESPERE-20170721Controlled Desaturation for Cerebral Oximetry
CHAP14-13755A Pragmatic Multicenter Randomized Trial Antihypertensive Therapy for Mild Chronic Hypertension during Pregnancy:
CHARTChemicals in Assisted Reproductive Technology (ChART): [SMART MODIFIED PROTOCOL] - EXPOSURE TO PHTHALATES & REPRODUCTIVE TOXICITY IN ASIAN & WHITE IVF COUPLES
CHORDSAn Open-Label Study To Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Relapsing Remitting Multiple Sclerosis Who Have Had A Suboptimal Response to an Adequate Course of Disease Modifying Treatment
CIRB-SWOG-1605Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
CIRTCardiovascular Inflammation Reduction Trial. (CIRT)
CL010-168A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis Treated Concomitantly with Rituximab or Cyclophosphamide/Azathioprine
CLN-PRO-V004A Phase 2 Study for the Evaluation of Safety and Efficacy of Humacyte s Human Acellular Vessel for Use as a Vascular Prosthesis for Femoro-Popliteal Bypass in Patients with Peripheral Arterial Disease
CLTD5685Clinical Evaluation of the Cochlear Nucleus® CI532 Cochlear Implant in Adults
CLUESCalifornia Lupus Epidemiology Study
CN002012A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravenously Administered BMS-986168 in Participants with Progressive Supranuclear Palsy with an Open-Label Extension
COL-HIV-401Collection of HIV-1-Positive Blood Samples; Collection of Blood Samples from a Population at High Risk for Contracting HIV-1
COMPASSION-S3COMPASSION S3: COngenital Multicenter trial of Pulmonic vAlve dysfunction Studying the SAPIEN 3 interventIONal THV
CONAClinical Trial of NAC in Asthma
COV-CEREBRAL-OXIMETRYControlled desaturation for cerebral oximetry
CRAD001A2433A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor vs. mycophenolate with standard calcineurin inhibitor in de novo renal transplantation Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM)
CREST2Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
CSF-BLOODBANKBanking of Cerebrospinal Fluid and/or Peripheral Blood from patients with Multiple Sclerosis, Neuromyelitis optica and other neurological diseases or from healthy subjects.
CTCHPRole of chitin and telomere dysfunction in chronic hypersensitivity pneumonitis
CTOT-19Randomized Controlled Trial of Infliximab Induction Therapy for Deceased Donor Kidney Transplant Recipients
CTOTC-12Safety of Donor Alloantigen Reactive Tregs (darTregs) to Facilitate Minimization and/or Discontinuation of Immunosuppression in Adult Liver Transplant Recipients (ARTEMIS)
CTSU-NCCTG-N1048A Phase II/III trial of Neoadjuvant FOLFOX, with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision
CTSU-NRG-HN001Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
CTSU-S1207Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer
CTSU-S1320A Randomized, Phase II Trial of Intermittent Versus Continuous Dosing of Dabrafenib (NSC-763760) and Trametinib (NSC-763093) in BRAFV600E/K Mutant Melanoma
CVHRStudy Comparing the Efficacy, Safety, and Cost of a Permanent, Synthetic Prosthetic Versus a Biologic Prosthetic in the One-stage Repair of Ventral Hernias in Clean and Contaminated Wounds.
DAA-SALVAGEA Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir/Pibrentasvir (G/P) +/- Ribavirin for GT1 Subjects with Chronic Hepatitis C Previously Treated with an NS5A Inhibitor + Sofosbuvir Therapy
DBS-TINNITUSU01Pilot Study of Deep Brain Stimulation in Area LC for Chronic Tinnitus
DBSVOPThalamic DBS for Secondary Dystonia
DFI12712A phase 2/3, multicenter, randomized, double-blinded, placebo-controlled, repeat-dose study to evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics of olipudase alfa in patients with acid sphingomyelinase deficiency
DIABETES-PORE-CONTENTRevealing the nature and longitudinal evolution of type 2 diabetic bone disease
DIAMANTEImproving diabetes and depression self-management via adaptive mobile messaging
DINE-CDOpen Label, Randomized, Multicenter, Comparative Effectiveness Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission in Patients with Crohn s Disease
E4FREEDOMA Multicenter, Open-label, Single-Arm Study to Evaluate the Contraceptive Efficacy and Safety of a Combined Oral Contraceptive Containing 15 mg Estetrol and 3 mg Drospirenone
EG-01-1962-03PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY COMPARING EG-1962 TO STANDARD OF CARE ORAL NIMODIPINE IN ADULTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE
EG-01-1962-04MULTICENTER, CONTROLLED, RANDOMIZED, SAFETY AND PHARMACOKINETIC STUDY COMPARING INTRACISTERNAL EG-1962 TO STANDARD OF CARE ENTERAL NIMODIPINE IN ADULTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE
ENDPLATE-1Phenotypes of pathologic verterbral endplate degeneration
EPI-589EPI589-15-002: A Phase 2A Safety and Biomarker Study of EPI-589 in Mitochondrial Subtype and Idiopathic Parkinson's Disease Subjects
EPI-CELLInvestigation of p63+ epithelial cells in endocervix and endometrium among healthy ovulating women
EPICMultiple Sclerosis Genetics-Expressions, Proteomics, Imaging, Clinical (MS Genes-EPIC Study)
ESETTEstablished Status Epilepticus Treatment Trial
ETN20130207A Multicenter Double-blind, Randomized Controlled Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With Psoriatic Arthritis
EXGENRectal and Oropharyngeal Swabs to Diagnose Gonococcal and Chlamydial Infection in Men and Women
EXPAND-IIInternational Trial to Evaluate the Safety and Effectiveness of the Portable Organ Care System (OCS ) Lung System for Recruiting, Preserving and Assessing Non-Ideal Donor Lungs for Transplantation (EXPAND II Trial
EXTENDITN058AI Preserving Beta-Cell Function with Tocilizumab in New-onset Type 1 Diabetes Protocol ITN058AI
FARAG[18F] F-AraG Biodistribution PET Imaging in Humans
FASTFirst-line Antimetabolites as Steroid-sparing Treatment Uveitis Trial
FIRSTTComparing MRgFUS versus UAE for Uterine Fibroids
FIXITA Prospective Randomized Trial to Assess Fixation Strategies for Severe Open Tibia Fractures: Modern Ring External Fixators vs. Internal Fixation (FIXIT Study)
FLX-787-203A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects with Motor Neuron Disease
FRAILTY-LUNGTRANSPLANTThe impact of pre-operative frailty and sarcopenia on outcomes following lung transplantation.
FTD-PPGFrontotemporal Dementia: Genes, Images and Emotions
FTY720D2399A single arm, open-label, multicenter study evaluating the long-term safety , and tolerability of 0.5 mg fingolimod (FTY720) administered orally once daily in patients with relapsing forms of multiple sclerosis
GA28950PHASE III, DOUBLE BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY OF THE EFFICACY AND SAFETY OF ETROLIZUMAB DURING INDUCTION AND MAINTENANCE IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS WHO ARE REFRACTORY TO OR INTOLERANT OF TNF INHIBITORS
GA28951AN OPEN-LABEL EXTENSION AND SAFETY MONITORING STUDY OF MODERATE TO SEVERE ULCERATIVE COLITIS PATIENTS PREVIOUSLY ENROLLED IN ETROLIZUMAB PHASE II/III STUDIES
GA39831An Observational Study to Assess Disease-Relevant Outcomes Using Home Monitoring Devices in Patients with Idiopathic Pulmonary Fibrosis
GB28547A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, STUDY TO ASSESS THE EFFICACY AND SAFETY OF LEBRIKIZUMAB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
GCAGenetics of Cardiac Arrhythmias
GCA-APEXZZ Genetics of Cardiac Arrhythmias
GED-0301-CD-002A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF MONGERSEN (GED-0301) FOR THE TREATMENT OF SUBJECTS WITH ACTIVE CROHN S DISEASE
GEENIUS-PERFORMANCEPerformance Evaluation of the Bio-Rad Geenius™ HIV-1/2 Supplemental Assay
GENEIMMUNEGenetic Basis of Immune System Disorders
GENENTECCOTTONWOODGA28951AN OPEN-LABEL EXTENSION AND SAFETY MONITORING STUDY OF MODERATE TO SEVERE ULCERATIVE COLITIS PATIENTS PREVIOUSLY ENROLLED IN ETROLIZUMAB PHASE II/III STUDIES - Cottonwood GA28951
GENENTECHBERGGA29144A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ETROLIZUMAB AS AN INDUCTION AND MAINTENANCE TREATMENT FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN S DISEASE
GENENTECHHICKORYGA28950PHASE III, DOUBLE BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF ETROLIZUMAB DURING INDUCTION AND MAINTENANCE IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS WHO ARE REFRACTORY TO OR INTOLERANT OF TNF INHIBITORS
GENENTECHJUNIPERGA29145An Open-Label Extension And Safety Monitoring Study of Patients With Moderately to Severely Active Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Protocol GA29144
GENENTECHLAURELGA29102PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY (MAINTENANCE OF REMISSION) AND SAFETY OF ETROLIZUMAB COMPARED WITH PLACEBO IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS WHO ARE NAIVE TO TNF INHIBITORS
GN29632A PHASE IB, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PARALLEL-ARM, MULTIPLE-DOSE STUDY TO ASSESS THE SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS, AND IMMUNOGENICITY OF INTRAVENOUS CRENEZUMAB ADMINISTERED IN PATIENTS WITH MILD TO MODERATE ALZHEIMER S DISEASE
GOG-3009A Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
GS-US-248-0122A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection
GS-US-320-4018A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Switching from Tenofovir Disoproxil Fumarate (TDF) 300 mg QD to Tenofovir Alafenamide (TAF) 25mg QD in Subjects with Chronic Hepatitis B who are Virologically Suppressed
GS-US-380-4030A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Switching from a Regimen of Dolutegravir and Either Emtricitabine/Tenofovir Alafenamide or Emtricitabine/Tenofovir Disoproxil Fumarate to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Subjects who are Virologically Suppressed
GS-US-384-1943A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
GS-US-384-1944A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)
GS-US-427-4024A Phase 2, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Primary Biliary Cholangitis Without Cirrhosis
GS-US-428-4025A Phase 2, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Primary Sclerosing Cholangitis Without Cirrhosis
GS1113GS-US-334-1113: A Phase 4, a Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trial
GX28228A PHASE II, MULTICENTER, RANDOMIZED, ACTIVE TREATMENT−CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF THE RANIBIZUMAB PORT DELIVERY SYSTEM FOR SUSTAINED DELIVERY OF RANIBIZUMAB IN PATIENTS WITH SUBFOVEAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
GX29176A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM- CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF LAMPALIZUMAB ADMINISTERED INTRAVITREALLY TO PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
GX30191A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF LAMPALIZUMAB IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION WHO HAVE COMPLETED A ROCHE-SPONSORED STUDY
HBCRNObservational Study of Persons with Hepatitis B Virus Infection in North America (Cohort Study)
HEARTASSIST5A Prospective, Randomized, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the HeartAssist 5® VAD System Compared to the HeartMate II® VAD and HVAD® for Left Ventricular Support in Patients Awaiting Cardiac Transplantation
HELLMAN-10-01981Effects of Toll-like receptor 2 activation on inflammation, coagulation and thrombosis, and endothelial cell function in vitro
HEMODIL-CASMED-20151117Accuracy of non-invasive measurement of hemoglobin concentration
HIVTR-CCR5Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
HIVTR-EVEImpact of Everolimus on HIV Persistence Post Kidney (and Kidney/Pancreas) or Liver Transplant
HIVTR-HOPEA Prospective Observational Study of Solid Organ Transplantation Utilizing HIV-Positive Donors in HIV-Positive Recipients
HOLIDAYThe HOLIDAY (HOw ALcohol InDuces Atrial TachYarrhythmias) Study
HPTN083A Phase 2b/3 Double Blind Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women who have Sex with Men
HW006A Prospective, Single Arm, Multi-Center Clinical Study in Collaboration with the InterAgency Registry for Mechanically Assisted Circulatory Support (INTERMACS®) to Evaluate the Thoracotomy Implant Technique of the HeartWare HVAD® System in Patients with Advanced Heart Failure
IDEALMRI-Based Measurements of Fatty Infiltration of the Rotator Cuff Muscles
IDN-6556-17A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects with Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
INO-PD-P3-2014A randomized, double-blind, placebo-controlled trial of urate-elevating inosine treatment to slow clinical decline in early Parkinson s disease
INS011-14-030A multicenter, open-label, flexible dose study to assess the long-term safety of pharmaceutical Cannabidiol Oral Solution as an adjunctive treatment for pediatric and adult subjects with a treatment-resistant seizure disorder who complete INS011-14-029, INS011-14-024, or INS011-14-025
INVOCELLComparing intra-vaginal culture of embryos using INVOcell device to in-vitro culture of embryos
ITN056STEvaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Operational Tolerance Following Liver Transplantation in Adults
JYU-ABone Marrow Cytogenetic Test Validation for UCSF Clinical Laboratories
KANSUIImmunologic response to Euphorbia kansui extract prepared as tea in HIV-infected antiretroviral therapy (ART)-suppressed individuals: a dose escalation study
KD019-211A Double-blind Randomized Parallel Group Study of the Efficacy and Safety of Tesevatinib in Subjects with Autosomal Dominant Polycystic Kidney Disease
KOO-PHOTOMEDEXExcimer Laser Phototherapy Outcomes in the Treatment of Psoriasis: A randomized clinical trial to determine whether a novel plaque-based dosimetry strategy can improve the speed of response to treatment in patients with plaque psoriasis
L-OR-UL-CARTILAGE-APEX1ZZ Loaded and Unloaded MR Imaging of Meniscus-Cartilage-Trabecular Bone in Osteoarthritis
LAB-REPRODUCIBILITY-STUDYLaboratory reproducibility of biochemical markers of bone turnover in clinical practice
LEEPLosartan Effects on Emphysema Progression
LIA-MRSA-375Cobas MRSA/SA nucleic acid test for use on the Cobas Liat System: clinical performance evaluation
LIPID-T1DCharacterization of Lipid Metabolism in Type 1 Diabetes and Relationship to Blood Sugar Control
LONG-TERM-IVFLong term health effect of assisted reproduction on childhood health
LSS17001A Concurrently Controlled Study of the LimiFlex™ Paraspinous Tension Band in the Treatment of Lumbar Degenerative Spondylolisthesis with Spinal Stenosis
LTLT-REGISTRYOptimizing liver and cardiovascular health after pediatric liver transplant: a longitudinal cohort study
LUNGTRANSPLANT-HRQLThe effects of lung transplantation on functional limitations and disability on patients with end-stage lung disease
LUTREPULSE-HHA Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered via OmniPod Pump for Ovulation Induction in Female Subjects with Hypogonadotropic Hypogonadism
M14-327A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of ABT-494 in Subjects with Crohn's Disease
M15-562A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Progressive Supranuclear Palsy
M15-563Phase 2 extension of Study M15-562 to assess the long-term safety, tolerability, and efficacy of ABBV-8E12 in subjects with progressive supranuclear palsy (PSP)
M15-566A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects with Early Alzheimer's Disease
M16-126A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Adults with Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection
MAGNAPMagnetic Apnea Prevention (MAGNAP) Device to Treat Obstructive Sleep Apnea: First In Human Study of Feasibility and Safety
MBN-101A Phase 2a Randomized, Single-Blind, Placebo-Controlled, 24-week Escalating Dose Study to Assess the Safety, Tolerability and Clinical Activity of 3 Concentrations of Locally Applied MBN-101 to Infected Osteosynthesis Sites
MD1003CT201601MSSPI2Effect of MD1003 in progressive multiple sclerosis: a randomized double blind placebo controlled study
METHB-MASIMO-20160618Accuracy of detection of methemoglobin with pulse oximetry
METHB-NIHO07-20160329NIHO07: Accuracy of Detection of Methemoglobin with Pulse Oximetry
METHB-NK-20150106Accuracy of detection of methemoglobin with pulse oximetry
METHB-NONIN-20141015Accuracy of detection of methemoglobin with pulse oximetry
MICRO-PDMicrobiota Intervention to Change the Response of Parkinson’s Disease (MICRO-PD)
MIDLIFE-STRESSWomen's Perceptions of Stress and Health Status Across Midlife
MINDDMetformin, Vitamin D, and Depression in PCOS (MINDD) Trial
MINDMAZEA Study of Virtual Reality Mediated Brain Recovery Using Functional MRI and MEG Imaging
MK-3682-041A Phase 2, Open-Label Clinical Trial to Study the Efficacy and Safety of 12 weeks of the Combination Regimen of MK-3682 + MK-8408 in Subjects with Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 3, 4, 5 or 6 Infection
MK8228-002A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of MK-8228 (Letermovir) Versus Valganciclovir for the Prevention of Human Cytomegalovirus (CMV) Disease in Adult Kidney Transplant Recipients
MNK14042068A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
MOLTOModels for Optimal Liver Transplant Outcomes (MOLTO)
MOTOR-STUDYMS130204 - Neuronal Determinants of Motor Disability in MS
MRGFUSA Phase III Clinical Trial to Compare ExAblate Magnetic Resonance Imaging Guided High Intensity Focused Ultrasound with Computed Tomography Guided Radiofrequency Ablation for Treatment of Medically Refractory Osteoid Osteomas
NAC-PILOTPhase II randomized, placebo- controlled, parallel group, double blinded single center study on effect of N-acetyl cysteine compared to placebo on fatigue in patients with progressive multiple sclerosis
NAFLDNonalcoholic Fatty Liver Disease (NAFLD) Database
NANOMIXEvaluation of the Levels of Troponin I, in a Normal Healthy Population when tested with the Nanōmix eLab System
NANT-2004-05NANT2004-05: Neuroblastoma Biology Study
NANT-2011-04A Phase I Study of Lenalidomide and Anti-GD2 Mab Ch14.18 +/- Isotretinoin in Patients with Refractory/Recurrent Neuroblastoma
NANT-2013-02A Phase I Study of Sorafenib and Cyclophosphamide/Topotecan in Patients with Relapsed and Refractory Neuroblastoma
NANT-2015-01Neuroblastoma Precision Trial
NATURALHX-SLEThe Natural History, Pathogenesis, and Disease Analysis of Systemic Lupus Erythematosus
NATURALHXSPAThe Natural History and Pathogenesis of Spondyloarthritis
NHORA NATURAL HISTORY OBSERVATION AND REGISTRY STUDY OF MACULAR TELANGIECTASIA TYPE 2: THE MACTEL STUDY
NM002Clinical Development and Evaluation of the Nociscan Diagnostic Software Suite for Post-Processing MRI and MR Spectroscopy (MRS) of Lumbar Intervertebral Discs to Diagnose Disc Pain and Degeneration
NONI45-HEMODIL-20160913NONI45 - Accuracy of non-invasive measurement of hemoglobin concentration
NSR-XLRP-OS1Natural History of the Progression of X-Linked Retinitis Pigmentosa
NUVIEW-VPACDetection of prostate cancer cells through the VPAC1 receptor
OMEGA-SPMTHE OMEGA-SPM-DOSE and OMEGA-SPM-PAD STUDIES: Specialized Pro-Resolving Mediators in Patients with Peripheral Artery Disease
ONE-FREEZE-1SF2014ONE FREEZE: A prospective multi-center randomized controlled trial to assess the safety and efficacy of one vs. two cryoablations per pulmonary vein for the treatment of atrial fibrillation
ONEDARTREG14Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation: A ONE Study Clinical Trial
OPPSOutpatient Performed Pterygium Surgery Study
ORTHOFIXSafety and Efficacy of Pulsed Electromagnetic Fields (Cervical-Stim®) as an Adjunct to Enhance Union in Conservatively Treated Type II Fractures of the Odontoid Process
P15-05(OLIF25™/OLIF51™ Study): A Multi-Center, Prospective, Observational Study to Assess Outcomes for Patients Treated for Lumbar Spinal Conditions Using an OLIF25™ and/or OLIF51™Approach
P3EGSProgram in Prenatal and Pediatric Genome Sequencing (P3EGS)
PAKTPAKT Biospecimen Registry
PARITYProhpylactic Antibiotic Regimens in Tumor Surgery (PARITY): A Multi-Center Randomized Controlled Study Comparing Alternative Antibiotic Regimens in Patients Undergoing Tumor Resections with Endoprosthetic Replacements
PB-WOTFORHEPCEvaluation of Wirelessly Observed Therapy to Optimize Adherence in Patients with Hepatitis C and Increased Risk for Nonadherence to Treatment
PBTC-029BA Phase I and Phase II and Re-Treatment Study of AZD6244 for Recurrent or Refractory Pediatric Low Grade Glioma
PEARL2Pathway Exploration and Analysis in Renal Lupus (PEARL) Phase 2
PETAL-ROSEReevaluation of Systemic Early Neuromuscular Blockade
PGN-001Clinical Evaluation of the PartoSure Test
PIRCLADPirfenidone for Restrictive Chronic Lung Allograft Dysfunction
PO1PROJECT2A Comprehensive Model of Severity of Outcomes in Ankylosing Spondylitis
POLYCYSTICKIDNEYDISEASE2A Phase 3b, Multi-center, Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan (OPC 41061, 30 mg to 120 mg/day, Split dose) in Subjects with Autosomal Dominant Polycystic Kidney Disease
POUCHITISFMTFecal Microbiota Transplant for Pouchitis
PPG-IPFBiomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis
PRETXPTMS-PERITOProspective pilot study of metabolic syndrome in pediatric liver transplant recipients
PRIORITIZETHE PRIORITIZE STUDY: A Pragmatic, Randomized of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
PRM-151-202A Phase 2 Trial to Evaluate the Efficacy of PRM-151 in Subjects with Idiopathic Pulmonary Fibrosis (IPF)
PRO-ACTPrevention of De Novo HCV with Antiviral HCV Therapy Post Liver Transplant
PRT-201-320Multicenter, Double-Blind, Placebo-Controlled Study of Vonapanitase (PRT-201) Administered Immediately after Radiocephalic Arteriovenous Fistula Creation in Patients with Chronic Kidney Disease
PSP-SAL-001A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
PSP-YP-001A 6 Month, Open-Label, Pilot Futility Clinical Trial of Monthly Young Healthy Male Donor Plasma Transfusions for Progressive Supranuclear Palsy
PSYFIPsychosocial Outcomes of Multiple Gestations General Information Questionnaire
PT1701Intraoperative variations in Pleth Variability Index (PVI)
PTMS-PED-LIVER-TRANSPLANTCauses and consequences of post-transplant metabolic syndrome in pediatric liver transplant recipients
PVO-1A-301A Phase 3, Efficacy and Safety Study of Oral Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
RA-ILDUnderstanding Rheumatoid Arthritis-Associated Interstitial Lung Disease
RECYCLE-1414550The Effects of a Reduced-function ABCG2 variant on the Pharmacokinetic and Pharmacodynamic Parameters of Allopurinol
RECYCLE884Clinical Evaluation of the QuantiFERON CMV Assay
REGENERATEA Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis
RENAL-DTIDiffusion Tensor Imaging in Pediatric Renal Transplants: Testing A Potential Non-Invasive Alternative to Biopsy
REP0112A phase 2/3, multicenter, randomized, double-blind, placebo-controlled, parallel assignment study to assess the efficacy and safety of reparixin in pancreatic islet auto-transplantation.
RESOLVE-ITA Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis
RETHINCREdefining Therapy IN early COPD
REUSE-16-18944Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Registry
RINPH202An Open-Label Extension study of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease
RPC01-1001A PHASE 1, MULTICENTER, RANDOMIZED, 12-WEEK, OPEN-LABEL STUDY TO EVALUATE THE MULTIPLE-DOSE PHARMACOKINETICS AND PHARMACODYNAMICS OF RPC1063 IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
RPC01-3001A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
RPC01-3101A phase 3, multicenter, randomized, double-blind, placebo controlled trial of oral RPC1063 as induction and maintenance therapy for moderate to severe ulcerative colitis
RPC01-3102A Phase 3, Multicenter, Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
SARPNIH/NHLBI Severe Asthma Research Program
SB-525-1603A Phase 1/2 , Open-Label, Adaptive, Dose-Ranging Study to Assess the Safety and Tolerability of SB-525 (recombinant AAV2/6 human Factor 8 Gene Therapy) in Adult Subjects with Severe Hemophilia A
SCORSpecialized Centers of Research (SCOR) on Sex Differences
SCORE2Study of Comparative Treatments in Retinal Vein Occlusion 2
SCY-078-301Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 in Patients with Fungal Diseases that are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)
SDIISpreading Depolarizations II (SDII): Development and Validation of Spreading Depolarization Monitoring for TBI Management
SEAMUSSEAMUS: Strictly Eating And Microbiome in Ulcerative Colitis
SHEAFStudy of hyperkyphosis, exercise and function-SHEAF
SHP616-302A randomized double-blind placebo-controlled study to evaluate the efficacy and safety of Cinryze® (C1 esterase inhibitor [human]) for the treatment of acute antibody-mediated rejection in kidney transplant patients
SIPSThe Impact of Seizures in Infants and Children with Ischemic Stroke (SIPS)
SJM-CIP-10113DRG Post-Approval Study
SJOGRENSMEDIMMUNEA Phase 2a, Randomized, Placebo-controlled, Proof of Mechanism Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Subjects with Primary Sjogren s Syndrome
SONATASeparating Ocular Neuropathy And True dry eye: Automated Analysis
SPIROMICSSubpopulations and Intermediate Outcome Measures in COPD Study
SPIROMICS-APEX1ZZ Subpopulations and Intermediate Outcome Measures in COPD Study
SPIROMICS-APEX2ZZ Subpopulations and Intermediate Outcome Measures in COPD Study 2
SPIROMICS-APEX3ZZ Subpopulations and Intermediate Outcome Measures in COPD Study 3
STANDARD-ANA-20150128Accuracy of pulse oximeters with profound hypoxia
STANDARD-BLU05-20150708Accuracy of pulse oximeters with profound hypoxia
STANDARD-COR-20140211Accuracy of pulse oximeters with profound hypoxia
STANDARD-DYNO-20170201Accuracy of pulse oximeters with profound hypoxia
STANDARD-FUKU01-20151110Accuracy of pulse oximeters with profound hypoxia
STANDARD-GOOGLE-20150211Accuracy of pulse oximeters with profound hypoxia
STANDARD-IVYBIOM-20140612Accuracy of pulse oximeters with profound hypoxia
STANDARD-IVYBIOM-20150624Accuracy of pulse oximeters with profound hypoxia
STANDARD-KONI07-20150916Accuracy of pulse oximeters with profound hypoxia
STANDARD-LIFEBOX-20170127Accuracy of pulse oximeters with profound hypoxia
STANDARD-MASI121-20151013Accuracy of pulse oximeters with profound hypoxia
STANDARD-MEDT-20171027Accuracy of pulse oximeters with profound hypoxia
STANDARD-MORT01-20151008Accuracy of Pulse Oximeters with Profound Hypoxia
STANDARD-NIHO06-20160329NIHO06: Accuracy of Detection of Carboxyhemoglobin with Pulse Oximetry
STANDARD-NK-20140416Accuracy of pulse oximeters with profound hypoxia
STANDARD-OWLET-20170510Accuracy of pulse oximeters with profound hypoxia
STANDARD-PEEL01-20151210Accuracy of Pulse Oximeters with Profound Hypoxia
STANDARD-PHIL01-20160509Accuracy of pulse oximeters with profound hypoxia
STANDARD-SCAN04-20150826Accuracy of Pulse Oximeters with Profound Hypoxia
STANDARD-SCANADU-20140613Accuracy of pulse oximeters with profound hypoxia
STANDARD-SENTEC-20140813Accuracy of pulse oximeters with profound hypoxia
STANDARD-SLEEP-20140625Accuracy of pulse oximeters with profound hypoxia
STANDARD-SNAP40-20180118Accuracy of pulse oximeters with profound hypoxia
STANDARD-SOMN01-20160321SOMN01: Accuracy of Pulse Oximeters with Profound Hypoxia
STANDARD-SPRING-20140827Accuracy of pulse oximeters with profound hypoxia
STANDARD-SPRY-20170601Accuracy of pulse oximeters with profound hypoxia
STANDARD-TRUE-20170106Accuracy of pulse oximeters with profound hypoxia
STANDARD-VERI01-20160418Accuracy of pulse oximeters with profound hypoxia
STANDARD-VIOS-20170201Accuracy of pulse oximeters with profound hypoxia
STOP-COA Pilot Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir and Ledipasvir for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
STRESS-DEPRESSIONPro-inflammatory Cytokine Glucocorticoid Resistance in Adults with Depression
STROKEAFStroke AF
SYNT001-102A Phase 1b, Multicenter, Open-Label, Safety, Tolerability, and Activity Study of SYNT001 in Subjects with Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA)
TACL-2014-001A Phase I Trial of Temsirolimus (CCI-779, Pfizer, Inc.) in Combination with Etoposide and Cyclophosphamide in Children with Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
TAPTTechnology-assisted postural training (TAPT) for older community-dwelling adults
TASKCTOT21Treg Adoptive Therapy in Subclinical Inflammation in Kidney Transplantation (TASK)
TED-SBS-EXTENSIONA Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Patients with Short Bowel Syndrome Who Completed TED-C14-006
TIDESTYPE 1 DIABETES EXTENSION STUDY
TILTA Phase 1 Trial of CD4+CD127lo/-CD25+ Polyclonal Treg Adoptive Immunotherapy with Interleukin-2 for the Treatment of Type 1 Diabetes
TINNITUS-DODTinnitus Multimodal Imaging
TN-19ATGGCSFAntithymocyte Globulin (ATG) and pegylated granulocyte colony stimulating factor (GCSF) in New Onset Type 1 Diabetes
TN20Exploring Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TrialNet Protocol TN-20)
TNF-ALPHATNF-alpha monoclonal antibody therapy for non-surgical dolichoectatic vertebrobasilar aneurysm
TRANSPLANTBIOMARKERSBiomarkers and Mechanisms of Disease and Organ Transplantation
TREGS-TRANSPLANTATIONExpansion of Human Regulatory T Cells for Use in Transplantation
TRIUMPHANT-MSTreatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis
TV5600-CNS-20006A Multinational, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Once Daily Oral Administration of Laquinimod (0.6 or 1.5 mg) in Patients with Primary Progressive Multiple Sclerosis (PPMS) Phase 2 Study TV5600-CNS-20006 (ARPEGGIO - A Randomized Placebo-controlled trial Evaluating laquinimod in PPMS, Gauging Gradations In MRI and clinical Outcomes)
U01AG045390Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects
UC-SAL-AD-001A Phase 1b, 12-Month, Randomized, Double-Blind, Placebo Controlled Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Salsalate in Patients with Mild to Moderate Alzheimer s Disease
UCDC-5101Longitudinal Study of Urea Cycle Disorders
USOI124A Prospective Observational Trial to Evaluate the Correlation of T-SPOT Response to CMV Infection and T cell-mediated Acute Graft Rejection
UX007-TRIHEPTANOINAn Open-label Long-Term Safety and Efficacy Extension Study in Subjects with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Previously Enrolled in UX007 or Triheptanoin Studies
VEOIBD-BIOREPOSITORYVery Early Onset Inflammatory Bowel Disease (VEOIBD) Biospecimen Repository Project
VIOLETVitamin D to Improve Outcomes by Leveraging Early Treatment
VTS301A Phase 2b/3 Prospective, Randomized, Double-Blind, Sham-Controlled Trial of VTS-270 (2-hydroxypropyl-β-cyclodextrin) in Subjects with Neurologic Manifestations of Niemann-Pick Type C1 (NPC1) Disease
WALNUT-DIABETESWalnuts to Achieve Lasting NUTrition to prevent Diabetes (WALNUT-Diabetes)
WPO1-ORGANOXA multicenter randomized controlled trial to compare the efficacy of ex-vivo normothermic machine perfusion with static cold storage in human liver transplantation
WT29749A PHASE Ib, SINGLE AND MULTIPLE-DOSE, OPEN LABEL STUDY OF THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF OBINUTUZUMAB IN ADULTS WITH END-STAGE RENAL DISEASE AND HYPERSENSITIZATION AWAITING RENAL TRANSPLANTATION
XTRACUtilizing a Multi-Micro Dose (MMD) Tip and Optimal Therapeutic UVB Dose Protocol (OTD) to Treat Plaque Psoriasis
ZX008-1601A Two-Part Study of ZX008 in Children and Adults with Lennox-Gastaut Syndrome (LGS); Part 1: A Multicenter, Randomized, Double-blind, Parallel Group, Placebocontrolled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as Adjunctive Therapy for Seizures in Children and Adults with LGS, Followed by Part 2: An Open-Label Extension Trial to Assess Long-Term Safety of ZX008 in Children and Adults with LGS
ZZFMTIBDFecal Microbiota Transplant for Inflammatory Bowel Disease
ZZPOUCHREGISTRYObservational pouch registry with stool sample collection and microbiome analysis